Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Nuclear Medicine

Free Subscription Articles published in J Nucl Cardiol Retrieve available abstracts of 345 articles: HTML format

Single Articles

November 2025
1. KADOYA Y, Boczar K, Tavoosi A, Small GR, et al
   Diagnostic Utility of Longitudinal Flow Gradient for Diagnosis of Obstructive CAD in Rubidium-82 Positron Emission Tomography.
   J Nucl Cardiol. 2025 Nov 29:102586. doi: 10.1016/j.nuclcard.2025.102586.
   PubMed     Abstract available
   
   
   
2. AHMED AI, Csecs I, Wright C, Kyriakoulis I, et al
   A Comparative Analysis of CZT SPECT/CT to Conventional SPECT and PET: Implications for Risk Stratification.
   J Nucl Cardiol. 2025 Nov 29:102583. doi: 10.1016/j.nuclcard.2025.102583.
   PubMed    
   
   
   
3. SARWAR S, Kadoya Y, Small GR, Chow BJW, et al
   Positron Emission Tomography Myocardial Perfusion Imaging Findings in Patients with Systemic Vasculitis.
   J Nucl Cardiol. 2025 Nov 28:102580. doi: 10.1016/j.nuclcard.2025.102580.
   PubMed    
   
   
   
4. MILLER RJH, Shanbhag A, Shahi K, Bosley D, et al
   Artificial Intelligence-Driven Longitudinal Quantification of Technetium Pyrophosphate Uptake in Cardiac Amyloidosis: Correlation with Multimodality Imaging and Outcomes.
   J Nucl Cardiol. 2025 Nov 26:102573. doi: 10.1016/j.nuclcard.2025.102573.
   PubMed     Abstract available
   
   
   
5. APHALE P, Shekhar H, Dokania S
   Refining Quantitative SPECT/CT in Transthyretin Cardiac Amyloidosis: Toward Standardized Clinical Application.
   J Nucl Cardiol. 2025 Nov 26:102571. doi: 10.1016/j.nuclcard.2025.102571.
   PubMed    
   
   
   
6. ZHANG D, Gu Y, Liu H, Ding D, et al
   Pharmacokinetic modelling of dynamic (99m)Tc-4BOH SPECT for myocardial perfusion imaging in patients with coronary artery disease.
   J Nucl Cardiol. 2025 Nov 21:102570. doi: 10.1016/j.nuclcard.2025.102570.
   PubMed     Abstract available
   
   
   
7. SPERRY BW, Godwin LA, Hutt E, Case JA, et al
   Quantitative Changes Between 1 and 3 hours in Technetium Pyrophosphate Cardiac Amyloid SPECT Imaging.
   J Nucl Cardiol. 2025 Nov 21:102568. doi: 10.1016/j.nuclcard.2025.102568.
   PubMed    
   
   
   
8. WANG K, Li X, Song S, Li H, et al
   Quantifying Right Ventricular Fibrosis Burden in CTEPH via FAPI SPECT/CT: Correlation with Echocardiographic Parameters and BPA Response.
   J Nucl Cardiol. 2025 Nov 20:102565. doi: 10.1016/j.nuclcard.2025.102565.
   PubMed     Abstract available
   
   
   
9. NIELSEN MO, Lassen ML, Zerahn B, Kjaer A, et al
   Evaluation of Rest (82)Rb PET as an Alternative to (99m)Tc-Based Monitoring of Cardiac Function During Chemotherapy.
   J Nucl Cardiol. 2025 Nov 20:102567. doi: 10.1016/j.nuclcard.2025.102567.
   PubMed    
   
   
   
10. ASSANTE R, Zampella E, D'Antonio A, Mannarino T, et al
    Improved risk stratification with non-invasive measures of myocardial flow reserve by low-dose dynamic imaging by CZT-SPECT in patients with suspected or known CAD.
    J Nucl Cardiol. 2025 Nov 20:102564. doi: 10.1016/j.nuclcard.2025.102564.
    PubMed    
    
    
    
11. SHAIKH A, Alwan M, Sayed A, El-Yaman A, et al
    Obesity Based Modulation of PET Myocardial Blood Flow Reserve.
    J Nucl Cardiol. 2025 Nov 13:102538. doi: 10.1016/j.nuclcard.2025.102538.
    PubMed    
    
    
    
12. HEDEER F, Kvernby S, Oddstig J, Engblom SA, et al
    Head-to-head comparison of left ventricular volumes and ejection fraction by [(13)N]ammonia positron emission tomography, myocardial perfusion single-photon emission computed tomography with cadmium-zinc-telluride technology and cardiac magnetic reson
    J Nucl Cardiol. 2025 Nov 7:102542. doi: 10.1016/j.nuclcard.2025.102542.
    PubMed     Abstract available
    
    
    
13. KHAN MS, Bateman TM, Case JA, Sperry BW, et al
    Beyond Flow Reserve: Comparative Prognostic Value of Myocardial Blood Flow Reserve, Peak Stress Myocardial Blood Flow, and Blood Flow Reserve Corrected for Resting Rate Pressure Product in Patients Undergoing PET Myocardial Perfusion Imaging.
    J Nucl Cardiol. 2025 Nov 6:102540. doi: 10.1016/j.nuclcard.2025.102540.
    PubMed     Abstract available
    
    
    
14. DOUKKY R
    Heart Rate Response to Regadenoson Stress with PET MPI: Old Marker, New Insights.
    J Nucl Cardiol. 2025 Nov 5:102557. doi: 10.1016/j.nuclcard.2025.102557.
    PubMed    
    
    
    
15. FEHER A, Sinusas AJ
    Confirming Expectations - Coronary Artery Calcification Assessment Provides Diagnostic Value in F18-flurpiridaz PET Myocardial Perfusion Imaging.
    J Nucl Cardiol. 2025 Nov 4:102559. doi: 10.1016/j.nuclcard.2025.102559.
    PubMed    
    
    
    
16. KERO T, Knuuti J, Bar S, Bax JJ, et al
    Stenosis degree and plaque burden differ between the major epicardial coronary arteries supplying ischemic territories.
    J Nucl Cardiol. 2025;53:102470.
    PubMed     Abstract available
    
    
    
17. MAHDI RA, Singh H, Ilangovan J, Dahiya N, et al
    Coronary anatomy matters: Dual LAD presenting as atypical ischemia on myocardial perfusion imaging.
    J Nucl Cardiol. 2025;53:102205.
    PubMed     Abstract available
    
    
    October 2025
18. MAJOR JD, Weinberg RL, Bourgeault BIng V, Harel F, et al
    Reduced Occupational Radiation Exposure After Rubidium-82 PET Adoption: A 10-Year Observational Study.
    J Nucl Cardiol. 2025 Oct 31:102541. doi: 10.1016/j.nuclcard.2025.102541.
    PubMed    
    
    
    
19. ALAHDAB F, El Shawi R, Ahmed AI, Al Rifai M, et al
    Improving Prognostic Risk Assessment of Cardiovascular Events with Machine Learning: An Evaluation Using PET Myocardial Perfusion Imaging.
    J Nucl Cardiol. 2025 Oct 30:102539. doi: 10.1016/j.nuclcard.2025.102539.
    PubMed     Abstract available
    
    
    
20. SOBY JH, Mortensen J, Rasmussen LD, Tolbod LP, et al
    Systematic Differences in Myocardial Blood Flow and Flow Reserve Quantification Using Rubidium-82 and [(15)O]H(2)O PET: Implications for Prognostic Cut-Offs.
    J Nucl Cardiol. 2025 Oct 17:102533. doi: 10.1016/j.nuclcard.2025.102533.
    PubMed     Abstract available
    
    
    
21. HYUN MC, Brown A, Calnon DA
    SCANNER ROOM CRISIS: Bridging THE WORKFORCE SHORTAGE GAP of Nuclear Medicine Technologists.
    J Nucl Cardiol. 2025 Oct 17:102527. doi: 10.1016/j.nuclcard.2025.102527.
    PubMed    
    
    
    
22. BARRETT O, Shanbhag A, Zaid R, Miller RJH, et al
    Incremental diagnostic value of AI-derived coronary artery calcium in (18)F-flurpiridaz PET Myocardial Perfusion Imaging.
    J Nucl Cardiol. 2025 Oct 14:102532. doi: 10.1016/j.nuclcard.2025.102532.
    PubMed     Abstract available
    
    
    
23. LIMA RSL, de Lorenzo A, Palazzo IC, Mesquita CT, et al
    How to Perform Quantification of Myocardial Blood Flow using SPECT MPI How to use Nuclear Cardiology.
    J Nucl Cardiol. 2025 Oct 14:102534. doi: 10.1016/j.nuclcard.2025.102534.
    PubMed    
    
    
    
24. MOULTON E, Gagliano L, Kaviani S, Klein R, et al
    Artificial Intelligence-enabled parametric mapping of myocardial blood flow with (82)Rb PET compared to (18)F-flurpiridaz perfusion imaging: A paired pilot study of image quality.
    J Nucl Cardiol. 2025 Oct 13:102531. doi: 10.1016/j.nuclcard.2025.102531.
    PubMed    
    
    
    
25. WANG Y
    Beyond Rest-Stress: Expanding Rapid (18)F-Flurpiridaz PET to Post-Stress Viability and Quantifying Coronary Flow Reserve.
    J Nucl Cardiol. 2025 Oct 10:102529. doi: 10.1016/j.nuclcard.2025.102529.
    PubMed    
    
    
    
26. SAYED A, Al Rifai M, El Yaman A, Alwan M, et al
    Differential Association of Heart Rate Response to Regadenoson with Death and Heart Failure Hospitalizations According to Ejection Fraction in Patients Undergoing PET MPI.
    J Nucl Cardiol. 2025 Oct 8:102508. doi: 10.1016/j.nuclcard.2025.102508.
    PubMed     Abstract available
    
    
    
27. ACAMPA W, Cantoni V
    Positron emission tomography computed tomography versus cadmium zinc telluride single-photon emission computer tomography in myocardial flow quantification: Bridging the gap or replacing a standard?
    J Nucl Cardiol. 2025;52:102443.
    PubMed    
    
    
    
28. DI CARLI MF
    What if SPECT could do it all?
    J Nucl Cardiol. 2025;52:102510.
    PubMed    
    
    
    
29. CSECS I, Sharma A, Khungar V, Sinusas AJ, et al
    Blunted hemodynamic response to pharmacological stress is predictive of mortality in liver transplant candidates.
    J Nucl Cardiol. 2025;52:102454.
    PubMed     Abstract available
    
    
    September 2025
30. PASCALE R, Fernandez-Hidalgo N, Tazza B, Bartoletti M, et al
    How to manage patients receiving long-term suppressive antibiotic treatment for infective endocarditis: the role of [18F]-FDG-PET/CT imaging - An international multidisciplinary survey.
    J Nucl Cardiol. 2025 Sep 27:102505. doi: 10.1016/j.nuclcard.2025.102505.
    PubMed    
    
    
    
31. KHAN MS, Perumalla HS, Modi K, Asif T, et al
    National Trends in Radiopharmaceutical Use for the Diagnosis of Cardiac Amyloidosis from 2019-2024.
    J Nucl Cardiol. 2025 Sep 26:102502. doi: 10.1016/j.nuclcard.2025.102502.
    PubMed    
    
    
    
32. DALEBOUT EM, Hirsch A, Mulders TA, Segbers M, et al
    Optimization of timing window and gating method for (18)F-FDG PET/CT in patients with suspected prosthetic valve endocarditis: A prospective pilot study.
    J Nucl Cardiol. 2025 Sep 20:102501. doi: 10.1016/j.nuclcard.2025.102501.
    PubMed    
    
    
    
33. PACKARD RRS, Maddahi J, Pelletier-Galarneau M, Al-Mallah MH, et al
    SNMMI/EANM/ASNC/ACNM procedure standard/practice guideline for (18)F-Flurpiridaz PET myocardial perfusion imaging and blood flow quantitation.
    J Nucl Cardiol. 2025 Sep 18:102473. doi: 10.1016/j.nuclcard.2025.102473.
    PubMed     Abstract available
    
    
    
34. MILLER RJH, Barrett O, Shanbhag A, Rozanski A, et al
    Integrating Perfusion with AI-derived Coronary Calcium on CT attenuation scans to improve selection of low-risk studies for stress-only SPECT MPI.
    J Nucl Cardiol. 2025 Sep 10:102482. doi: 10.1016/j.nuclcard.2025.102482.
    PubMed     Abstract available
    
    
    
35. LIMA BB, Kronenberg MW, Carr CM, Duran J, et al
    How to Prepare Patients for (18)F-FDG PET Myocardial Viability Assessment.
    J Nucl Cardiol. 2025 Sep 2:102480. doi: 10.1016/j.nuclcard.2025.102480.
    PubMed    
    
    
    
36. AJIMA T, Aikawa T, Saitou T, Matsue Y, et al
    Prognostic value of (99m)Tc-pyrophosphate uptake in patients with suspected transthyretin cardiac amyloidosis.
    J Nucl Cardiol. 2025;51:102452.
    PubMed     Abstract available
    
    
    
37. BENZ DC, Flammer AJ, Schwotzer R, Buechel RR, et al
    How to perform and interpret cardiac amyloidosis radionuclide imaging (CARI).
    J Nucl Cardiol. 2025;51:102448.
    PubMed     Abstract available
    
    
    August 2025
38. RAMIREZ G, Lemley M, Shanbhag A, Kwiecinski J, et al
    The REgistry of Flow and Perfusion Imaging for Artificial INtelligEnce with PET(REFINE PET): Rationale and Design.
    J Nucl Cardiol. 2025 Aug 5:102449. doi: 10.1016/j.nuclcard.2025.102449.
    PubMed     Abstract available
    
    
    
39. SCHERPING SC 3RD, Ahmad SM, Katz SM, Hosadurg N, et al
    The prevalence and prognostic impact of additive abnormal stress exercise markers in patients with normal stress myocardial perfusion imaging.
    J Nucl Cardiol. 2025;50:102267.
    PubMed     Abstract available
    
    
    July 2025
40. RENAUD JM, Moody JB, Vanderver MD, Poitrasson-Riviere A, et al
    Improved diagnostic performance of (18)F-flurpiridaz PET myocardial blood flow quantification with automated dynamic motion correction.
    J Nucl Cardiol. 2025 Jul 25:102450. doi: 10.1016/j.nuclcard.2025.102450.
    PubMed    
    
    
    
41. CLAUDIO FD, Siddiqui S, Gil FR, Morley-Smith A, et al
    Unmasking Deep Sternal Wound Infection After Cardiac Transplant: The Diagnostic and Monitoring Value of (18)F-FDG PET/CT.
    J Nucl Cardiol. 2025 Jul 25:102447. doi: 10.1016/j.nuclcard.2025.102447.
    PubMed    
    
    
    
42. GU Y, Sun R, Ren W, Xi X, et al
    Preclinical and first-in-human studies of a novel tracer for SPECT myocardial blood flow quantification.
    J Nucl Cardiol. 2025 Jul 15:102441. doi: 10.1016/j.nuclcard.2025.102441.
    PubMed     Abstract available
    
    
    
43. WANG S, Luan Q, Cheng Z, Li Y, et al
    (18)F-FAP-2286 and (18)F-FDG PET/CT imaging in a rare case of asymptomatic indolent cardiac hemangioma in the right ventricle.
    J Nucl Cardiol. 2025 Jul 15:102442. doi: 10.1016/j.nuclcard.2025.102442.
    PubMed    
    
    
    
44. HIJAZI W, Feng Y, Southern DA, Chew D, et al
    Corrigendum to "Association of medical therapies with survival according to SPECT MPI findings" [J Nucl Cardiol 3 May 2025; 102229].
    J Nucl Cardiol. 2025 Jul 15:102440. doi: 10.1016/j.nuclcard.2025.102440.
    PubMed    
    
    
    
45. ALI SM, Sathian B, Iqbal J, Muhammad K, et al
    Caution in Interpreting PET-Negative Fibrosis: Commentary on the Diagnostic Scope of 13N-Ammonia PET in Non-Ischemic Cardiomyopathies.
    J Nucl Cardiol. 2025 Jul 8:102300. doi: 10.1016/j.nuclcard.2025.102300.
    PubMed    
    
    
    
46. BROWN JM, Huck DM
    Total-Body PET: Investigating Mechanisms in Cardiovascular-Kidney-Metabolic Syndrome.
    J Nucl Cardiol. 2025 Jul 5:102299. doi: 10.1016/j.nuclcard.2025.102299.
    PubMed     Abstract available
    
    
    
47. WRIGHT CX, Spatz ES
    Leveraging stress testing as a risk modifier: Optimization of medical therapy after SPECT MPI.
    J Nucl Cardiol. 2025;49:102282.
    PubMed    
    
    
    
48. AL RIFAI M, Ahmed AI, Nayfeh M, Nabi F, et al
    The prognostic significance of rate pressure product corrected myocardial flow reserve.
    J Nucl Cardiol. 2025;49:102222.
    PubMed     Abstract available
    
    
    June 2025
49. SPILLER WH, SathyaMurthi B, Arumugam P
    Unexpected insight: Rubidium-82 PET/CT myocardial perfusion imaging uncovers malignant pleural mesothelioma.
    J Nucl Cardiol. 2025 Jun 16:102264. doi: 10.1016/j.nuclcard.2025.102264.
    PubMed    
    
    
    
50. YAHIRO DS, Silva LFLD, Junior GL, Al-Mallah MH, et al
    Comparison of PET-CT and CZT-SPECT on Myocardial Blood Flow and Flow Reserve measurement: a systematic review and meta-analysis.
    J Nucl Cardiol. 2025 Jun 15:102279. doi: 10.1016/j.nuclcard.2025.102279.
    PubMed     Abstract available
    
    
    
51. RENAUD JM, Moody JB, Vanderver MD, Poitrasson-Riviere A, et al
    Diagnostic performance of (18)F-flurpiridaz PET myocardial perfusion imaging with total perfusion deficit quantification.
    J Nucl Cardiol. 2025 Jun 15:102266. doi: 10.1016/j.nuclcard.2025.102266.
    PubMed     Abstract available
    
    
    
52. MALIK AP, Parvez Malik UF, Iqbal J, Sathian B, et al
    Comment on "Validation of [99mTc]Tc-HMDP SPECT/CT Myocardial Uptake Quantification for the Detection of ATTR Cardiomyopathy".
    J Nucl Cardiol. 2025 Jun 13:102272. doi: 10.1016/j.nuclcard.2025.102272.
    PubMed    
    
    
    
53. LEGALLOIS D, Turcan L, Agostini D, Manrique A, et al
    Test-retest Reproducibility of Myocardial (99m)Tc-HMDP Uptake Quantification by SPECT-CT in Suspected Transthyretin Cardiac Amyloidosis.
    J Nucl Cardiol. 2025 Jun 13:102273. doi: 10.1016/j.nuclcard.2025.102273.
    PubMed     Abstract available
    
    
    
54. ROMERO PABON AJ, Clerc OF, Cuddy SAM, Vijayakumar S, et al
    Prognostic Value of (99m)technetium-PYP SPECT Visual Grade in Patients with Transthyretin Cardiac Amyloidosis on Stabilization Therapy.
    J Nucl Cardiol. 2025 Jun 13:102275. doi: 10.1016/j.nuclcard.2025.102275.
    PubMed     Abstract available
    
    
    
55. CROWLEY LE, Jenkins E, Ranasinghe A, Naneishvili T, et al
    Serial (18)F-Fluorodeoxyglucose Positron Emission Tomography to Assess the Efficacy of Infliximab in Steroid Refractory Cardiac Sarcoidosis.
    J Nucl Cardiol. 2025 Jun 9:102265. doi: 10.1016/j.nuclcard.2025.102265.
    PubMed    
    
    
    
56. KADRMAS DJ, Kemp BJ, Sitek A, Chareonthaitawee P, et al
    Technical Evaluation of Immediate Back-to-Back Rest-Stress PET Scanning with (18)F-Flurpiridaz.
    J Nucl Cardiol. 2025 Jun 9:102268. doi: 10.1016/j.nuclcard.2025.102268.
    PubMed     Abstract available
    
    
    
57. FUJITO H, Lemley M, Builoff V, Zhang W, et al
    (82)Rb PET Myocardial Blood Flow Quantification: Influence of Arterial Input Curve Quality on Diagnostic Accuracy.
    J Nucl Cardiol. 2025 Jun 7:102270. doi: 10.1016/j.nuclcard.2025.102270.
    PubMed     Abstract available
    
    
    
58. MANABE O
    AI-driven quantification in (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: A step toward objectivity and reproducibility.
    J Nucl Cardiol. 2025;48:102224.
    PubMed    
    
    
    
59. AL RIFAI M, Alwan M, Ahmed AI, Nabi F, et al
    The impact of obesity on myocardial flow reserve and its prognostic utility.
    J Nucl Cardiol. 2025;48:102193.
    PubMed     Abstract available
    
    
    May 2025
60. ALWAN M, Sayed A, Ahmed AI, Shaikh A, et al
    The Impact of Attenuation Correction and Prone Positioning on Stress-Only Imaging in Cardiac SPECT: An Observational Study.
    J Nucl Cardiol. 2025 May 20:102249. doi: 10.1016/j.nuclcard.2025.102249.
    PubMed     Abstract available
    
    
    
61. DALEBOUT EM, Swart LE, Kluin J, Weustink AC, et al
    (18)F-FDG PET-CT in patients with prosthetic heart valves: variations in imaging findings: A review of the literature.
    J Nucl Cardiol. 2025 May 17:102247. doi: 10.1016/j.nuclcard.2025.102247.
    PubMed     Abstract available
    
    
    
62. ALWAN M, El Yaman A, Sayed A, Shaikh A, et al
    Cardiac Positron emission tomography/ computed tomography (PET/CT) in current cardiology guidelines.
    J Nucl Cardiol. 2025 May 8:102231. doi: 10.1016/j.nuclcard.2025.102231.
    PubMed     Abstract available
    
    
    
63. HIJAZI W, Feng Y, Southern DA, Chew D, et al
    Association of Medical Therapies with Survival According to SPECT MPI Findings.
    J Nucl Cardiol. 2025 May 3:102229. doi: 10.1016/j.nuclcard.2025.102229.
    PubMed     Abstract available
    
    
    
64. OSBORNE MT, Al-Mallah MH
    Probing the shadows of myocardial scar: Can PET MPI see what MRI sees?
    J Nucl Cardiol. 2025;47:102221.
    PubMed    
    
    
    
65. LEE SN, Malhotra P, Miller RJH, Gransar H, et al
    Independent prognostic significance of myocardial flow reserve over coronary artery calcium, myocardial perfusion, and clinical variables in patients without known coronary artery disease, according to diabetes status.
    J Nucl Cardiol. 2025;47:102165.
    PubMed     Abstract available
    
    
    
66. HSU TJ, Tseng CT, Kuo L, Yang CY, et al
    AHL amyloidosis mimicking transthyretin amyloidosis on cardiac Tc-99 m pyrophosphate scan: A diagnostic challenge.
    J Nucl Cardiol. 2025;47:102147.
    PubMed     Abstract available
    
    
    April 2025
67. SPRAUEL T, Imbert L, Doyeux K, Perrin M, et al
    Assessment of Sestamibi CZT-SPECT Reconstructed Using Deep-Learning-Based Virtual Attenuation Correction Maps According to Coronary Artery Territory and With Comparison to Rubidium-PET.
    J Nucl Cardiol. 2025 Apr 19:102226. doi: 10.1016/j.nuclcard.2025.102226.
    PubMed     Abstract available
    
    
    
68. SHINN K, Henderson CS, Schenone AL, Goonewardena SN, et al
    Can ChatGPT answer patients' questions about nuclear stress tests and (18)F-Flurodeoxyglucose PET for myocardial inflammation?
    J Nucl Cardiol. 2025 Apr 5:102174. doi: 10.1016/j.nuclcard.2025.102174.
    PubMed     Abstract available
    
    
    
69. DIVAKARAN S, Harms HJ, Robertson M, Merugumala SK, et al
    Post-walking exercise skeletal muscle perfusion and energetics in patients with symptomatic lower extremity peripheral artery disease.
    J Nucl Cardiol. 2025;46:102143.
    PubMed     Abstract available
    
    
    
70. CALLEGARI S, Mena-Hurtado C, Smolderen KG, Thorn S, et al
    New horizons in nuclear cardiology: Imaging of peripheral arterial disease.
    J Nucl Cardiol. 2025;46:102079.
    PubMed     Abstract available
    
    
    March 2025
71. SUOMALAINEN O, Ahokas T, Hippelainen E, Helio T, et al
    Validation of [(99m)Tc]Tc-HMDP SPECT/CT Myocardium-to-blood Ratio for the Detection of ATTR Cardiomyopathy.
    J Nucl Cardiol. 2025 Mar 28:102199. doi: 10.1016/j.nuclcard.2025.102199.
    PubMed     Abstract available
    
    
    
72. NAZIF K, Abuzaid AS, Horgan S, Patel KK, et al
    Role of Rubidium-82 positron emission tomography in a multimodality approach to diagnosing Coronary Microvascular Dysfunction in Apical Hypertrophic Cardiomyopathy.
    J Nucl Cardiol. 2025 Mar 25:102197. doi: 10.1016/j.nuclcard.2025.102197.
    PubMed    
    
    
    
73. NIKOLAKOPOULOS I, Csecs I, Liu YH, Sinusas AJ, et al
    Temporal changes in PET myocardial flow reserve: implications for cardiovascular outcomes.
    J Nucl Cardiol. 2025 Mar 24:102194. doi: 10.1016/j.nuclcard.2025.102194.
    PubMed     Abstract available
    
    
    
74. MILLER RJ, Shanbhag A, Marcinkiewicz AM, Struble H, et al
    AI-enabled CT-guided end-to-end quantification of total cardiac activity in 18FDG cardiac PET/CT for detection of cardiac sarcoidosis.
    J Nucl Cardiol. 2025 Mar 22:102195. doi: 10.1016/j.nuclcard.2025.102195.
    PubMed     Abstract available
    
    
    
75. HEINIGER PS, Igual GD, Galafton A, Albertini T, et al
    Impact of transmurality and location on the diagnostic performance of 13N-ammonia PET in the detection of myocardial fibrosis - A hybrid PET/MR study.
    J Nucl Cardiol. 2025 Mar 1:102172. doi: 10.1016/j.nuclcard.2025.102172.
    PubMed     Abstract available
    
    
    
76. PERRIN M, Claudin M, Djaballah K, Boursier C, et al
    Diagnostic accuracy of low-dose myocardial perfusion imaging in a real-world setting.
    J Nucl Cardiol. 2025;45:102140.
    PubMed     Abstract available
    
    
    
77. BUILOFF V, Shanbhag A, Miller RJ, Dey D, et al
    Evaluating AI proficiency in nuclear cardiology: Large language models take on the board preparation exam.
    J Nucl Cardiol. 2025;45:102089.
    PubMed     Abstract available
    
    
    
78. BOURQUE JM, Beanlands RSB, Berman DS, Chareonthaitawee P, et al
    F-18 flurpiridaz positron emission tomography myocardial perfusion imaging combined with treadmill exercise testing.
    J Nucl Cardiol. 2025;45S:102170.
    PubMed    
    
    
    
79. MADDAHI J
    (18)F flurpiridaz PET MPI: Imaging characteristics and clinical trials.
    J Nucl Cardiol. 2025;45S:102175.
    PubMed    
    
    
    
80. PATEL KK, Horgan S, Heller GV, Bateman TM, et al
    F-18-Flurpiridaz positron emission tomography myocardial perfusion imaging clinical results in specific patient populations.
    J Nucl Cardiol. 2025;45S:102166.
    PubMed    
    
    
    
81. DI CARLI MF
    The rise of quantitative positron emission tomography: Redefining the evaluation of coronary artery disease.
    J Nucl Cardiol. 2025;45S:102179.
    PubMed    
    
    
    
82. AL-MALLAH MH, Al Badarin F, Bengel F, Grossman GB, et al
    Potential worldwide impact of F-18 Flurpiridaz positron emission tomography myocardial perfusion imaging.
    J Nucl Cardiol. 2025;45S:102167.
    PubMed    
    
    
    
83. PACKARD RRS, deKemp RA, Knuuti J, Moody JB, et al
    Quantitative approaches to (18)F-flurpiridaz positron emission tomography image analysis.
    J Nucl Cardiol. 2025;45S:102180.
    PubMed    
    
    
    February 2025
84. OMOTE K, Oi M, Aikawa T
    Serial assessment of DWIBS-MRI and (18)F-fluorodexyglcose PET/CT after corticosteroid therapy in Takayasu arteritis.
    J Nucl Cardiol. 2025 Feb 28:102171. doi: 10.1016/j.nuclcard.2025.102171.
    PubMed    
    
    
    
85. XIE H, Alashi A, Thorn SL, Chen X, et al
    Increasing angular sampling for dedicated cardiac SPECT scanner: Implementation with Deep Learning and Validation with human data.
    J Nucl Cardiol. 2025 Feb 20:102168. doi: 10.1016/j.nuclcard.2025.102168.
    PubMed    
    
    
    
86. MOU T, Meng J, Lin C, Xie X, et al
    XTR003, a Fatty-acid Metabolism PET Tracer: A Phase I Study to Evaluate the Safety, Biodistribution, Radiation Dosimetry and Pharmacokinetics in Healthy Volunteers.
    J Nucl Cardiol. 2025 Feb 7:102144. doi: 10.1016/j.nuclcard.2025.102144.
    PubMed     Abstract available
    
    
    
87. TUBBEN A, Prakken NHJ, Ivashchenko OV, Tingen HSA, et al
    Feasibility of the Absolute Quantification and Left Ventricular Segmentation of Cardiac Sympathetic Innervation in Wild-type Transthyretin Amyloidosis Cardiomyopathy with [(123)I]-MIBG SPECT/CT: the I-NERVE study.
    J Nucl Cardiol. 2025 Feb 3:102146. doi: 10.1016/j.nuclcard.2025.102146.
    PubMed     Abstract available
    
    
    
88. NYE JA, Tipnis SV
    Addressing motion in the estimation of myocardial blood flow with [F-18] flurpiridaz positron emission tomography.
    J Nucl Cardiol. 2025;44:102123.
    PubMed    
    
    
    
89. RISCHPLER C
    'TIDing' over the uncertainty: Prognostic value of Transient Ischemic Dilation in Rubidium-82 PET myocardial perfusion imaging.
    J Nucl Cardiol. 2025;44:102142.
    PubMed    
    
    
    
90. MENGESHA B, Small G, Paterson DI, Chow B, et al
    Transient ischemic dilatation in cardiac amyloidosis.
    J Nucl Cardiol. 2025;44:102042.
    PubMed     Abstract available
    
    
    January 2025
91. WIEFELS C, Boczar K, Birnie D, Beanlands R, et al
    Quantification of metabolic activity in the evaluation of cardiac sarcoidosis.
    J Nucl Cardiol. 2025;43:102088.
    PubMed     Abstract available
    
    
    
92. TORRES A, Yerkan A, Abbasi A, Doukky R, et al
    The prognostic utility of heart rate and blood pressure response to regadenoson stress.
    J Nucl Cardiol. 2025;43:102050.
    PubMed     Abstract available
    
    
    
93. VEERWAL H, Preet K, Sood A, Singh H, et al
    Incidentally detected diaphragmatic eventration as para-cardiac thoracic activity on myocardial perfusion imaging.
    J Nucl Cardiol. 2025;43:101817.
    PubMed     Abstract available
    
    
    December 2024
94. LOGANATH K, Craig N, Barton A, Joshi S, et al
    Cardiovascular PET imaging of fibroblast activation A review of the current literature.
    J Nucl Cardiol. 2024 Dec 11:102106. doi: 10.1016/j.nuclcard.2024.102106.
    PubMed     Abstract available
    
    
    
95. WU J, Young BD, Liu H, Sadeghi MM, et al
    Parametric FDG PET K(i) images using dual-time-point imaging data for cardiac sarcoidosis: a proof of concept study.
    J Nucl Cardiol. 2024 Dec 7:102121. doi: 10.1016/j.nuclcard.2024.102121.
    PubMed    
    
    
    
96. CLERC OF, Saraste A
    The heart has a memory: Let's not forget to interrogate it with (18)F-FDG PET.
    J Nucl Cardiol. 2024;42:102087.
    PubMed    
    
    
    
97. ZHANG F, Yang X, Chen Y, Shao X, et al
    Incremental prognostic value of (18)F-fluorodeoxyglucose myocardial ischemic memory imaging for major adverse cardiovascular events in patients with suspected unstable angina.
    J Nucl Cardiol. 2024;42:102051.
    PubMed     Abstract available
    
    
    
98. LUCINIAN YA, Martineau P, Abikhzer G, Harel F, et al
    Novel tracers to assess myocardial inflammation with radionuclide imaging.
    J Nucl Cardiol. 2024;42:102012.
    PubMed     Abstract available
    
    
    November 2024
99. MOTWANI M
    I can see clearly now the blur has gone - deep learning efficiencies in SPECT myocardial perfusion imaging.
    J Nucl Cardiol. 2024 Nov 30:102091. doi: 10.1016/j.nuclcard.2024.102091.
    PubMed    
    
    
    
100. ROJULPOTE C, Bhattaru A, Patil S, Adams SL, et al
     Assessing the Effect of Repeat PET Imaging on Treatment Response and Cardiovascular Outcomes among a Homogenously Treated Cohort of Patients with Suspected Cardiac Sarcoidosis.
     J Nucl Cardiol. 2024 Nov 21:102082. doi: 10.1016/j.nuclcard.2024.102082.
     PubMed     Abstract available
     
     
     
101. KHOO CY, Maning J, Weinberg R, Avery R, et al
     Correlation between Technetium-99m pyrophosphate myocardial uptake and extracellular volume on cardiac magnetic resonance imaging in patients with transthyretin cardiac amyloidosis.
     J Nucl Cardiol. 2024 Nov 19:102083. doi: 10.1016/j.nuclcard.2024.102083.
     PubMed    
     
     
     
102. PATEL KK, Lim P, Peri-Okonny PA, Singh A, et al
     Prognostic value of Transient Ischemic Dilation on Rubidium-82 Positron Emission Tomography Myocardial Perfusion Imaging.
     J Nucl Cardiol. 2024 Nov 16:102084. doi: 10.1016/j.nuclcard.2024.102084.
     PubMed     Abstract available
     
     
     
103. TOUMA R, Njeim M, Jebara V, Abidov A, et al
     Cardiac PET and CMR in Diagnosis of Epi-pericardial Fat Necrosis Associated with Severe Refractory Chest Pain Following Arrhythmia Ablation.
     J Nucl Cardiol. 2024 Nov 15:102086. doi: 10.1016/j.nuclcard.2024.102086.
     PubMed    
     
     
     
104. TASAKA T, Ogimoto A, Saito M, Koike S, et al
     Assessing the effectiveness of tafamidis therapy in patients with transthyretin cardiac amyloidosis using (99m)technetium pyrophosphate cardiac imaging.
     J Nucl Cardiol. 2024 Nov 8:102075. doi: 10.1016/j.nuclcard.2024.102075.
     PubMed    
     
     
     
105. SATHYAMURTHI B, Sarish S, Khan MA, Arumugam P, et al
     Benefit of 82-Rubidium Positron Emission Tomography for risk stratification in a patient with Intrapericardial diaphragmatic hernia.
     J Nucl Cardiol. 2024 Nov 7:102070. doi: 10.1016/j.nuclcard.2024.102070.
     PubMed    
     
     
     
106. BUILOFF V, Huang C, Kuronuma K, Wei CC, et al
     Automatic motion correction for myocardial blood flow estimation improves diagnostic performance for coronary artery disease in (18)F-flurpiridaz PET-MPI.
     J Nucl Cardiol. 2024 Nov 5:102072. doi: 10.1016/j.nuclcard.2024.102072.
     PubMed     Abstract available
     
     
     
107. ZHANG X, Yang Y, Pretorius PH, Slomka PJ, et al
     Cardiac motion correction with a deep learning network for perfusion defect assessment in SPECT myocardial perfusion imaging.
     J Nucl Cardiol. 2024 Nov 2:102071. doi: 10.1016/j.nuclcard.2024.102071.
     PubMed     Abstract available
     
     
     
108. GAO D, Aykac M, Hayden C, Beanlands R, et al
     Rubidium-82 Dose Effects on Myocardial Blood Flow Measurements using a Digital PET-CT Scanner.
     J Nucl Cardiol. 2024 Nov 1:102073. doi: 10.1016/j.nuclcard.2024.102073.
     PubMed    
     
     
     
109. MURTHY VL
     Dawn of the cardiac PET era.
     J Nucl Cardiol. 2024;41:102055.
     PubMed    
     
     
     October 2024
110. ROZANSKI A, Gransar H, Miller RJ, Han D, et al
     Clinical Correlates of a Single-item Physical Activity Questionnaire among Patients Undergoing Stress SPECT Myocardial Perfusion Imaging.
     J Nucl Cardiol. 2024 Oct 30:102066. doi: 10.1016/j.nuclcard.2024.102066.
     PubMed     Abstract available
     
     
     
111. KURONUMA K, Rozanski A, Han D, Park R, et al
     Use of a Single-item Exercise Questionnaire Predicts Prognostic Risk among Patients undergoing Stress PET-MPI.
     J Nucl Cardiol. 2024 Oct 24:102065. doi: 10.1016/j.nuclcard.2024.102065.
     PubMed     Abstract available
     
     
     
112. KAMEL Y, Terrone D, Pelletier-Galarneau M
     Caseous Calcification as a Cause of False Positive FDG-PET/CT in Native Valve Endocarditis.
     J Nucl Cardiol. 2024 Oct 17:102058. doi: 10.1016/j.nuclcard.2024.102058.
     PubMed    
     
     
     
113. BOBER RM, Milani RV, Abelhad N, Velasco-Gonzalez C, et al
     Fast vs slow rubidium-82 infusion profiles and test-retest precision of myocardial perfusion using contemporary 3D cardiac analog PET-CT imaging.
     J Nucl Cardiol. 2024 Oct 17:102059. doi: 10.1016/j.nuclcard.2024.102059.
     PubMed     Abstract available
     
     
     
114. GODOY-RIVAS C, Elsadany M, Jaiswal A, Weissler-Snir A, et al
     SPECT/CT Quantification of 99m-TC PYP Uptake to Assess Tafamidis Treatment Response in ATTR Cardiac Amyloidosis.
     J Nucl Cardiol. 2024 Oct 8:102056. doi: 10.1016/j.nuclcard.2024.102056.
     PubMed     Abstract available
     
     
     
115. ROQUE A, Pizzi MN
     Infection vs inflammation in prosthetic heart valves by [(18)F]FDG-PET/CT: a practical tutorial for accurate interpretation.
     J Nucl Cardiol. 2024 Oct 4:102053. doi: 10.1016/j.nuclcard.2024.102053.
     PubMed    
     
     
     
116. POITRASSON-RIVIERE A, Vanderver MD, Hagio T, Arida-Moody L, et al
     Automated Deep Learning Segmentation of Cardiac Inflammatory FDG PET.
     J Nucl Cardiol. 2024 Oct 3:102052. doi: 10.1016/j.nuclcard.2024.102052.
     PubMed     Abstract available
     
     
     
117. DI CARLI MF
     Re-imagining risk stratification in high-risk patients: PET and SPECT myocardial perfusion imaging in focus.
     J Nucl Cardiol. 2024;40:102057.
     PubMed    
     
     
     
118. LIGA R, Giorgetti A, Bertasi M, Filidei E, et al
     Myocardial ischemia in patients with mild-to-moderate aortic stenosis: Interaction with cardiac remodeling and adverse events.
     J Nucl Cardiol. 2024;40:102017.
     PubMed     Abstract available
     
     
     
119. HAGE FG, Bourque JM, Pandey S, Shah NR, et al
     American Society of Nuclear Cardiology quality metrics for cardiac amyloid radionuclide imaging.
     J Nucl Cardiol. 2024;40:102041.
     PubMed     Abstract available
     
     
     September 2024
120. HASHIMOTO H, Kuronuma K, Hyun MC, Han D, et al
     Head-to-head comparison of (18)F-sodium fluoride coronary PET imaging between a silicon photomultiplier with digital photon counting and conventional scanners.
     J Nucl Cardiol. 2024 Sep 27:102045. doi: 10.1016/j.nuclcard.2024.102045.
     PubMed     Abstract available
     
     
     
121. SUAREZ JP, Dominguez ML, Vigil C, Fernandez B, et al
     Detection of small vegetations in native bi-valvular (aortic + mitral) infective endocarditis with 4D ECG-gated cardiac [(18)F]FDG PET/CT.
     J Nucl Cardiol. 2024 Sep 19:102043. doi: 10.1016/j.nuclcard.2024.102043.
     PubMed    
     
     
     
122. AUER B
     Parametric (82)Rb-Chloride PET Imaging of Myocardial Blood Flow: Ready for Clinical Prime Time?
     J Nucl Cardiol. 2024 Sep 14:102040. doi: 10.1016/j.nuclcard.2024.102040.
     PubMed    
     
     
     
123. ROZANSKI A, Berman D
     Evaluating the Prognostic Effectiveness of Stress SPECT versus PET Myocardial Perfusion Imaging.
     J Nucl Cardiol. 2024 Sep 12:102038. doi: 10.1016/j.nuclcard.2024.102038.
     PubMed    
     
     
     
124. JOHNSON NP, Gould KL
     How to differentiate obstructive from non-obstructive CAD with quantitative PET MPI using Coronary Flow Capacity.
     J Nucl Cardiol. 2024 Sep 10:102039. doi: 10.1016/j.nuclcard.2024.102039.
     PubMed    
     
     
     
125. DI CARLI MF
     Caravan of dreams: Precision quantitative imaging shaping the future of nuclear cardiology.
     J Nucl Cardiol. 2024;39:102044.
     PubMed    
     
     
     
126. TRAVIN MI
     Enhancing the utility of radionuclide adrenergic imaging for assessing the risk of sudden arrhythmic cardiac death.
     J Nucl Cardiol. 2024;39:102022.
     PubMed    
     
     
     
127. VIJAYAKUMAR S, Pabon AR, Clerc OF, Cuddy SAM, et al
     Quantitative (99m)Tc-pyrophosphate myocardial uptake: Changes on transthyretin stabilization therapy.
     J Nucl Cardiol. 2024;39:102019.
     PubMed     Abstract available
     
     
     August 2024
128. KAUR S, Chamseddine F, Abadie B, Sunder V, et al
     Regional Variation in Technetium Pyrophosphate (PYP) Uptake in Transthyretin Cardiac Amyloidosis (ATTR-CA) and Concomitant Myocardial Infarction: A Case Series.
     J Nucl Cardiol. 2024 Aug 29:102031. doi: 10.1016/j.nuclcard.2024.102031.
     PubMed    
     
     
     
129. AL-MALLAH M, Alwan M, Al Rifai M, Sayed A, et al
     Cardiac Positron Emission Tomography and Other Modalities for CAD Assessment: A Snapshot from the Medicare Data.
     J Nucl Cardiol. 2024 Aug 27:102030. doi: 10.1016/j.nuclcard.2024.102030.
     PubMed     Abstract available
     
     
     
130. PIZZI MN
     Does digital PET/CT represent a step forward in the diagnostic accuracy of infective endocarditis?
     J Nucl Cardiol. 2024 Aug 23:102024. doi: 10.1016/j.nuclcard.2024.102024.
     PubMed    
     
     
     
131. LEE JC, Chong JW, Hector BM
     Communication of unexpected nuclear medicine and PET findings is a two-way street.
     J Nucl Cardiol. 2024 Aug 15:102018. doi: 10.1016/j.nuclcard.2024.102018.
     PubMed    
     
     
     
132. HUNTER C, Moulton E, Beanlands R, deKemp R, et al
     Parametric Imaging of Myocardial Blood Flow with (82)Rb PET: An Accuracy and Image Quality Analysis.
     J Nucl Cardiol. 2024 Aug 10:102020. doi: 10.1016/j.nuclcard.2024.102020.
     PubMed     Abstract available
     
     
     
133. DI CARLI MF
     Targeted molecular imaging of myocardial infarction: One more step in the right direction.
     J Nucl Cardiol. 2024;38:102021.
     PubMed    
     
     
     
134. LU MT, Tawakol A
     Deeper insights from deep learning: Enhanced myocardial perfusion assessments using multimodal artificial intelligence.
     J Nucl Cardiol. 2024;38:102014.
     PubMed    
     
     
     
135. PELLETIER-GALARNEAU M
     Liver failure and myocardial perfusion imaging: Wake up and smell the coffee.
     J Nucl Cardiol. 2024;38:101904.
     PubMed    
     
     
     
136. AL-MALLAH MH, Al Rifai M, Saad JM
     The role of splenic switch-off in assessing vasodilator response: When less is more.
     J Nucl Cardiol. 2024;38:101896.
     PubMed    
     
     
     
137. KITKUNGVAN D, Johnson NP, Roby AE, Mendoza P, et al
     Quantitative myocardial perfusion in liver transplantation candidates: Poorly metabolized caffeine inhibition of vasodilatory stress.
     J Nucl Cardiol. 2024;38:101884.
     PubMed     Abstract available
     
     
     July 2024
138. NOTOHAMIPRODJO S, Scheidhauer K, Eiber M, Yakushev I, et al
     Impact of a dedicated cardiac protocol on diagnosis of infective endocarditis in patients undergoing [(18)F]-FDG-thoracic digital-PET/CT - Effects of expertise level.
     J Nucl Cardiol. 2024 Jul 27:102010. doi: 10.1016/j.nuclcard.2024.102010.
     PubMed     Abstract available
     
     
     
139. DAHDAL J, Jukema RA, Harms HJ, Cramer MJ, et al
     PET Myocardial Perfusion Imaging: Trends, Challenges, and Opportunities.
     J Nucl Cardiol. 2024 Jul 25:102011. doi: 10.1016/j.nuclcard.2024.102011.
     PubMed     Abstract available
     
     
     
140. ALI A, Lu Y, Khalaf S, Iliescu C, et al
     Use of Positron Emission Tomography for The Diagnosis of Immune Checkpoint Inhibitor Myocarditis.
     J Nucl Cardiol. 2024 Jul 23:101909. doi: 10.1016/j.nuclcard.2024.101909.
     PubMed    
     
     
     
141. HUA C, Xi XY, Zhang Y, Suo N, et al
     (99m)Tc-HFAPi SPECT Imaging Predicts Left Ventricular Remodeling After Acute Myocardial Infarction.
     J Nucl Cardiol. 2024 Jul 13:101910. doi: 10.1016/j.nuclcard.2024.101910.
     PubMed     Abstract available
     
     
     
142. HAGEN JM, Zacherl MJ, Brendel M, Clauss S, et al
     Quantitative assessment of cardiac (123)iodo-metaiodobenzylguanidine SPECT/CT in patients with arrhythmogenic right ventricular cardiomyopathy: novel insight in disease monitoring.
     J Nucl Cardiol. 2024 Jul 13:101911. doi: 10.1016/j.nuclcard.2024.101911.
     PubMed     Abstract available
     
     
     
143. HUCK DM, Divakaran S, Weber B, Brown JM, et al
     COMPARATIVE EFFECTIVENESS OF PET AND SPECT MPI FOR PREDICTING RISK IN PATIENTS WITH CARDIOMETABOLIC DISEASE.
     J Nucl Cardiol. 2024 Jul 10:101908. doi: 10.1016/j.nuclcard.2024.101908.
     PubMed     Abstract available
     
     
     
144. SHETTY M, Bullock-Palmer RP, Dorbala S, Chareonthaitawee P, et al
     #WINning together: Celebrating American Society of Nuclear Cardiology's women in nuclear cardiology initiative.
     J Nucl Cardiol. 2024;37:101905.
     PubMed    
     
     
     
145. SOMAN P, Hyafil F
     Resting myocardial blood flow: To correct, or not to correct, that is the question!
     J Nucl Cardiol. 2024;37:101902.
     PubMed    
     
     
     
146. DI CARLI MF
     July signals change: Welcoming new editorial voices and key clinical insights.
     J Nucl Cardiol. 2024;37:101906.
     PubMed    
     
     
     
147. MAANIITTY T, Knuuti J
     The additional value of relative assessment of quantitative myocardial blood flow.
     J Nucl Cardiol. 2024;37:101886.
     PubMed    
     
     
     
148. CHIH S, Tavoosi A, Beanlands RSB
     How to use nuclear cardiology to evaluate cardiac allograft vasculopathy.
     J Nucl Cardiol. 2024;37:101866.
     PubMed    
     
     
     
149. HUCK DM, Weber BN, Brown JM, Lopez D, et al
     Prognostic value of myocardial flow reserve vs corrected myocardial flow reserve in patients without obstructive coronary artery disease.
     J Nucl Cardiol. 2024;37:101854.
     PubMed     Abstract available
     
     
     June 2024
150. TEUHO J, Schultz J, Klen R, Juarez-Orozco LE, et al
     Explainable deep learning-based ischemia detection using hybrid O-15 H2O perfusion PET/CT imaging and clinical data.
     J Nucl Cardiol. 2024 Jun 7:101889. doi: 10.1016/j.nuclcard.2024.101889.
     PubMed     Abstract available
     
     
     
151. SELVARAJ S, Bravo PE
     How to Prepare a Patient for FDG PET Imaging to Assess Myocardial Inflammation.
     J Nucl Cardiol. 2024 Jun 1:101888. doi: 10.1016/j.nuclcard.2024.101888.
     PubMed    
     
     
     
152. DI CARLI MF
     Charting the future of nuclear cardiology: Innovation, creativity, and perseverance.
     J Nucl Cardiol. 2024;36:101890.
     PubMed    
     
     
     
153. KERR N, Miller RJH, Chew DS
     Can nuclear cardiology optimize cardiac resynchronization therapy lead placement: Paving the way to precision medicine?
     J Nucl Cardiol. 2024;36:101873.
     PubMed    
     
     
     
154. LIM P, Agarwal V, Patel KK
     How to assess nonresponsiveness to vasodilator stress.
     J Nucl Cardiol. 2024;36:101850.
     PubMed     Abstract available
     
     
     May 2024
155. JUAREZ-OROZCO LE
     Exploring PET-derived geometric indexes in ischemic heart disease - Is more in store?
     J Nucl Cardiol. 2024 May 15:101883. doi: 10.1016/j.nuclcard.2024.101883.
     PubMed    
     
     
     
156. ROQUE A, Pizzi MN
     PET/CT in aortic grafts: sufficient evidence or still leap of faith?
     J Nucl Cardiol. 2024 May 9:101882. doi: 10.1016/j.nuclcard.2024.101882.
     PubMed    
     
     
     
157. MANABE O, Tamaki N
     Revealing the Hidden Depths of Takotsubo Syndrome: The Crucial Role of PET in Understanding and Managing Cardiac Microvascular Dysfunction.
     J Nucl Cardiol. 2024 May 7:101878. doi: 10.1016/j.nuclcard.2024.101878.
     PubMed    
     
     
     
158. ZHANG Y, Bos E, Clarkin O, Wilson T, et al
     Interpretation of SPECT Wall Motion with Deep Learning.
     J Nucl Cardiol. 2024 May 7:101881. doi: 10.1016/j.nuclcard.2024.101881.
     PubMed     Abstract available
     
     
     
159. MARK PD, Prescott E, Marner L, Hovind P, et al
     [(15)O]H(2)O myocardial perfusion PET: Added value of relative stress perfusion deficit in the prediction of significant coronary artery stenosis in a mixed population.
     J Nucl Cardiol. 2024 May 4:101880. doi: 10.1016/j.nuclcard.2024.101880.
     PubMed     Abstract available
     
     
     
160. DECORADS CE, Lambert A, Roch V, Imbert L, et al
     Association between baseline hemodynamic indices, cardiotoxicity risk, and survival in women with breast cancer.
     J Nucl Cardiol. 2024;35:101849.
     PubMed     Abstract available
     
     
     April 2024
161. SI H, He Z, Malhotra S, Zhang X, et al
     A novel method combining gated SPECT and vectorcardiography to guide left ventricular lead placement to improve response to cardiac resynchronization therapy: A Proof of Concept study.
     J Nucl Cardiol. 2024 Apr 30:101867. doi: 10.1016/j.nuclcard.2024.101867.
     PubMed     Abstract available
     
     
     
162. BRORSON J, Gormsen LC, Madsen S, Tolbod LP, et al
     Splenic switch-off in [(15)O]H(2)O-PET myocardial perfusion imaging using parametric blood flow images.
     J Nucl Cardiol. 2024 Apr 27:101868. doi: 10.1016/j.nuclcard.2024.101868.
     PubMed     Abstract available
     
     
     
163. KADOYA Y, Chong AY, Small GR, Chow B, et al
     Myocardial flow reserve recovery in patients with Takotsubo syndrome: insights from positron emission tomography.
     J Nucl Cardiol. 2024 Apr 27:101869. doi: 10.1016/j.nuclcard.2024.101869.
     PubMed     Abstract available
     
     
     
164. HASSE B, Ledergerber B, Van Hemelrijck M, Frank M, et al
     FDG uptake patterns in PET/CT caused by inflammation and/or infection after graft surgery for thoracic aortic dissection.
     J Nucl Cardiol. 2024 Apr 26:101865. doi: 10.1016/j.nuclcard.2024.101865.
     PubMed     Abstract available
     
     
     
165. MARTINEZ-LUCIO TS, Alexanderson-Rosas E, Carvajal-Juarez I, Mendoza-Ibanez AK, et al
     Left ventricular shape index and eccentricity index with ECG-gated Nitrogen-13 ammonia PET/CT in patients with myocardial infarction, ischemia and normal perfusion.
     J Nucl Cardiol. 2024 Apr 10:101862. doi: 10.1016/j.nuclcard.2024.101862.
     PubMed     Abstract available
     
     
     
166. SPERRY BW, Vuppala S
     Sequential FDG PET Imaging in Cardiac Sarcoidosis.
     J Nucl Cardiol. 2024 Apr 5:101860. doi: 10.1016/j.nuclcard.2024.101860.
     PubMed    
     
     
     March 2024
167. TAVOOSI A, Paquin A, deKemp R, Chong AY, et al
     POSITRON EMISSION TOMOGRAPHY ASSESSMENT OF CORONARY MICROVASCULAR ANGINA IN PATIENTS WITH ANGINA AND NONOBSTRUCTIVE CORONARY ARTERY DISEASE.
     J Nucl Cardiol. 2024 Mar 25:101853. doi: 10.1016/j.nuclcard.2024.101853.
     PubMed    
     
     
     
168. ABU-QAMAR O, Biery DW, Mendonca LSM, Barrett L, et al
     Association between Abnormal Retinal Perfusion Indices by Optical Coherence Tomography Angiography and Myocardial Flow Reserve by PET/CT.
     J Nucl Cardiol. 2024 Mar 25:101852. doi: 10.1016/j.nuclcard.2024.101852.
     PubMed    
     
     
     
169. BALMFORTH C, Whittington B, Tzolos E, Bing R, et al
     Translational Molecular imaging: Thrombosis Imaging with Positron Emission Tomography.
     J Nucl Cardiol. 2024 Mar 16:101848. doi: 10.1016/j.nuclcard.2024.101848.
     PubMed     Abstract available
     
     
     
170. KWIECINSKI J
     Role of (18)F-sodium fluoride positron emission tomography in imaging atherosclerosis.
     J Nucl Cardiol. 2024 Mar 11:101845. doi: 10.1016/j.nuclcard.2024.101845.
     PubMed     Abstract available
     
     
     
171. OKAFOR J, Khattar R, Kouranos V, Ohri S, et al
     Role of serial (18)FDG-PET in determining the therapeutic efficacy of immunosuppression and clinical outcome in patients with cardiac sarcoidosis.
     J Nucl Cardiol. 2024 Mar 11:101842. doi: 10.1016/j.nuclcard.2024.101842.
     PubMed     Abstract available
     
     
     
172. RUDDY TD, Wells RG
     Shortening the Acquisition Times of CZT SPECT Imaging for Measurement of Myocardial Blood Flow.
     J Nucl Cardiol. 2024 Mar 9:101847. doi: 10.1016/j.nuclcard.2024.101847.
     PubMed    
     
     
     
173. DI CARLI MF
     How is PET/CT Imaging Revolutionizing Cardiac Care: Let me Count the Ways.
     J Nucl Cardiol. 2024 Mar 7:101844. doi: 10.1016/j.nuclcard.2024.101844.
     PubMed     Abstract available
     
     
     
174. PATEL KK, Singh A, Qarajeh R, Shatla I, et al
     Prevalence of Balanced Ischemia on PET Relative Perfusion Imaging Among Patients with High-Risk Coronary Artery Disease.
     J Nucl Cardiol. 2024 Mar 2:101836. doi: 10.1016/j.nuclcard.2024.101836.
     PubMed    
     
     
     
175. BOBER RM, Johnson NP
     How might coronary sinus reducer treatment change myocardial perfusion?
     J Nucl Cardiol. 2024;33:101828.
     PubMed    
     
     
     
176. AL RIFAI M, Winchester D
     When should myocardial perfusion imaging be a first-test choice?
     J Nucl Cardiol. 2024;33:101824.
     PubMed    
     
     
     
177. ZAMPELLA E, Assante R, Acampa W
     A good assist is followed by a goal.
     J Nucl Cardiol. 2024;33:101807.
     PubMed    
     
     
     
178. AKSIT E, Kirilmaz B, Ozdemir S
     The importance of myocardial perfusion imaging in patients with ischemia and nonobstructive coronary arteries.
     J Nucl Cardiol. 2024;33:101791.
     PubMed    
     
     
     February 2024
179. SOLANKI R, Singh H, Mehta V, Panda P, et al
     Potential application of (68)Ga-FAPI PET/CT for diagnosing cardiac sarcoidosis.
     J Nucl Cardiol. 2024 Feb 23:101835. doi: 10.1016/j.nuclcard.2024.101835.
     PubMed    
     
     
     
180. SEVAG PACKARD RR
     Expanding the Repertoire of (18)F-Labeled PET MPI Radiotracers.
     J Nucl Cardiol. 2024 Feb 23:101834. doi: 10.1016/j.nuclcard.2024.101834.
     PubMed    
     
     
     
181. LIU A, Cain L, Munemo LT, Ahmed R, et al
     Characterisation and management of expected and unexpected urgent findings from FDG-PET-CT in cardiovascular disease.
     J Nucl Cardiol. 2024 Feb 20:101826. doi: 10.1016/j.nuclcard.2024.101826.
     PubMed     Abstract available
     
     
     
182. WANG J, Chen Y, Chu H, Pang Z, et al
     Feasibility of Myocardial Blood Flow Quantification to Detect Flow-limited Coronary Artery Disease with A One-day Rest/Stress Continuous Rapid Imaging Protocol on Cardiac-dedicated CZT SPECT.
     J Nucl Cardiol. 2024 Feb 20:101825. doi: 10.1016/j.nuclcard.2024.101825.
     PubMed     Abstract available
     
     
     
183. REN C, Pan Q, Fu C, Wang P, et al
     Phase I, first-in-human study of XTR004, a novel (18)F-labeled tracer for myocardial perfusion PET: biodistribution, radiation dosimetry, pharmacokinetics and safety after a single injection at rest.
     J Nucl Cardiol. 2024 Feb 13:101823. doi: 10.1016/j.nuclcard.2024.101823.
     PubMed     Abstract available
     
     
     
184. BOURQUE JM, Birgersdotter-Green U, Bravo PE, Budde RPJ, et al
     (18)F-FDG PET/CT and radiolabeled leukocyte SPECT/CT imaging for the evaluation of cardiovascular infection in the multimodality context: ASNC Imaging Indications (ASNC I(2)) Series Expert Consensus Recommendations from ASNC, AATS, ACC, AHA, ASE, EANM
     J Nucl Cardiol. 2024 Feb 12:101786. doi: 10.1016/j.nuclcard.2023.101786.
     PubMed     Abstract available
     
     
     
185. DI CARLI MF
     Navigating the positron emission tomography vs. single-photon emission computed tomography debate: A closer look at evidence and guidelines.
     J Nucl Cardiol. 2024 Feb 2:101822. doi: 10.1016/j.nuclcard.2024.101822.
     PubMed    
     
     
     January 2024
186. BHATTARU A, Rojulpote C, Vidula M, Duda J, et al
     Deep Learning Approach for Automated Segmentation of Myocardium Using Bone Scintigraphy SPECT/CT in Patients with Suspected Cardiac Amyloidosis.
     J Nucl Cardiol. 2024 Jan 31:101809. doi: 10.1016/j.nuclcard.2024.101809.
     PubMed     Abstract available
     
     
     
187. HAN Y, Ahmed AI, Saad JM, Alahdab F, et al
     Ejection Fraction And Ventricular Volumes On Rubidium Positron Emission Tomography: Prospective Validation Against Cardiovascular Magnetic Resonance.
     J Nucl Cardiol. 2024 Jan 27:101810. doi: 10.1016/j.nuclcard.2024.101810.
     PubMed     Abstract available
     
     
     
188. FUJIOKA K, Norikane T, Takami Y, Yamamoto Y, et al
     Feasibility of PiB PET/CT for treatment monitoring with Tafamidis in a patient with ATTR-CA.
     J Nucl Cardiol. 2024 Jan 19:101816. doi: 10.1016/j.nuclcard.2024.101816.
     PubMed    
     
     
     
189. DIETZ M, Bochaton T, Al Mansour L, Tordo J, et al
     Identification of lipomatous metaplasia on CT images helps confirm prior silent myocardial infarction associated with equivocal perfusion abnormality on SPECT/CT imaging.
     J Nucl Cardiol. 2024 Jan 19:101812. doi: 10.1016/j.nuclcard.2024.101812.
     PubMed    
     
     
     
190. WILLIAMS MC
     Machine learning models for PET myocardial perfusion imaging.
     J Nucl Cardiol. 2024 Jan 18:101805. doi: 10.1016/j.nuclcard.2024.101805.
     PubMed    
     
     
     
191. ROZANSKI A, Miller RJH, Han D, Gransar H, et al
     Comparative Predictors of Mortality among Patients Referred for Stress SPECT versus PET Myocardial Perfusion Imaging.
     J Nucl Cardiol. 2024 Jan 18:101811. doi: 10.1016/j.nuclcard.2024.101811.
     PubMed     Abstract available
     
     
     
192. CHENG K, Tan ST, Wechalekar K, Keramida G, et al
     Redistribution of myocardial perfusion after coronary sinus reducer implantation demonstrated by rubidium-82 positron emission tomography.
     J Nucl Cardiol. 2024 Jan 12:101803. doi: 10.1016/j.nuclcard.2024.101803.
     PubMed    
     
     
     
193. SANGHANI R, Al-Mallah MH, Thompson R
     Challenges and Strategies to enable access to Cardiac PET in Different Parts of the World: The North American Perspective.
     J Nucl Cardiol. 2024 Jan 10:101790. doi: 10.1016/j.nuclcard.2023.101790.
     PubMed    
     
     
     
194. BORGES-ROSA J, Oliveira-Santos M, Silva R, Elvas L, et al
     (18)F-FDG PET-CT FOR DIAGNOSING CUTANEOUS FISTULAS SECONDARY TO RETAINED LEAD FRAGMENTS: A RARE AND CHALLENGING COMPLICATION AFTER PACEMAKER EXTRACTION.
     J Nucl Cardiol. 2024 Jan 6:101794. doi: 10.1016/j.nuclcard.2024.101794.
     PubMed    
     
     
     
195. BAILLY M, Gamet A, Metrard G
     Potential utility of myocardial blood flow quantification with SPECT in a patient undergoing treatment for breast cancer.
     J Nucl Cardiol. 2024 Jan 5:101799. doi: 10.1016/j.nuclcard.2024.101799.
     PubMed    
     
     
     
196. FUJIOKA K, Norikane T, Takami Y, Yamamoto Y, et al
     Feasibility of PiB PET/CT for treatment monitoring with Tafamidis in a patient with ATTR-CA.
     J Nucl Cardiol. 2024 Jan 5:101800. doi: 10.1016/j.nuclcard.2024.101800.
     PubMed    
     
     
     
197. BERMAN D, Hunter C, Hossain A, Yao J, et al
     Machine and deep learning models for accurate detection of ischemia and scar with myocardial blood flow PET imaging.
     J Nucl Cardiol. 2024 Jan 5:101797. doi: 10.1016/j.nuclcard.2024.101797.
     PubMed     Abstract available
     
     
     
198. GAEMPERLI O
     Ejection fraction and ventricular volumes on Rb PET: Validation against cardiovascular MRI.
     J Nucl Cardiol. 2024 Jan 4:101795. doi: 10.1016/j.nuclcard.2024.101795.
     PubMed    
     
     
     
199. HOFF CM, Sorensen J, Kero T, Bouchelouche K, et al
     Quantitative and qualitative comparison of Rubidium-82 and Oxygen-15 water cardiac PET.
     J Nucl Cardiol. 2024 Jan 4:101796. doi: 10.1016/j.nuclcard.2024.101796.
     PubMed     Abstract available
     
     
     
200. ABAZID RM, Davey RA, Romsa J, Florendo-Cumbermack A, et al
     Progressive development of cardiac amyloidosis in a hereditary transthyretin gene carrier on serial Tc-99m PYP SPECT-CT.
     J Nucl Cardiol. 2024;31:101774.
     PubMed    
     
     
     
201. CROWLEY A, Gerson M
     The future of PET imaging: Looking forward to more choices and increased precision with the use of oxygen-15 water.
     J Nucl Cardiol. 2024;31:101775.
     PubMed    
     
     
     
202. SUERO-ABREU GA, Lim P, Raza A, Tysarowski M, et al
     Effect of variable left ventricular ejection fraction assessed by equilibrium radionuclide angiocardiography using different software packages on the diagnosis of cardiotoxicity in patients with cancer.
     J Nucl Cardiol. 2024;31:101782.
     PubMed     Abstract available
     
     
     
203. DI CARLI MF, Gormsen LC, Chareonthaitawee P, Johnson GB, et al
     Rationale and design of the RAPID-WATER-FLOW trial: Radiolabeled perfusion to identify coronary artery disease using water to evaluate responses of myocardial FLOW.
     J Nucl Cardiol. 2024;31:101779.
     PubMed     Abstract available
     
     
     December 2023
204. ARUMUGAM P, Better N, Keng FY, Allam A, et al
     Current state and challenges of implementing a cardiac positron emission tomography program outside North America.
     J Nucl Cardiol. 2023;31:101788.
     PubMed    
     
     
     
205. DANAD I, Driessen RS
     Utility of (82)Rb and [(15)O]H(2)O PET myocardial perfusion imaging in challenging (high risk) patients: "Don't throw the baby out with the bathwater".
     J Nucl Cardiol. 2023 Dec 2:101783. doi: 10.1016/j.nuclcard.2023.101783.
     PubMed    
     
     
     
206. HUDSON O, Hage FG
     Single photon emission computed tomography pyrophosphate imaging for transthyretin cardiac amyloid.
     J Nucl Cardiol. 2023;30:2615-2617.
     PubMed    
     
     
     
207. ROZANSKI A, Gransar H, Sakul S, Miller RJH, et al
     Increasing frequency of dyspnea among patients referred for cardiac stress testing.
     J Nucl Cardiol. 2023;30:2303-2313.
     PubMed     Abstract available
     
     
     
208. AL-MALLAH MH
     ASNC without borders: A global effort in nuclear cardiology.
     J Nucl Cardiol. 2023;30:2972-2975.
     PubMed    
     
     
     
209. NAKAJIMA K, Shibutani T, Massanes F, Shimizu T, et al
     Myocardial perfusion imaging with retrospective gating and integrated correction of attenuation, scatter, respiration, motion, and arrhythmia.
     J Nucl Cardiol. 2023;30:2773-2789.
     PubMed     Abstract available
     
     
     
210. LI L, Gao J, Chen BX, Liu X, et al
     Fibroblast activation protein imaging in atrial fibrillation: a proof-of-concept study.
     J Nucl Cardiol. 2023;30:2712-2720.
     PubMed     Abstract available
     
     
     
211. MATTHEWS B, Duddleston D, Hage FG
     Myocardial perfusion imaging in congenitally corrected transposition of the great arteries.
     J Nucl Cardiol. 2023;30:2907-2910.
     PubMed    
     
     
     
212. YU W, Yang L, Zhang F, Liu B, et al
     Machine learning to predict hemodynamically significant CAD based on traditional risk factors, coronary artery calcium and epicardial fat volume.
     J Nucl Cardiol. 2023;30:2593-2606.
     PubMed     Abstract available
     
     
     
213. LASSEN ML, Byrne C, Hartmann JP, Kjaer A, et al
     Pulmonary blood volume assessment from a standard cardiac rubidium-82 imaging protocol: impact of adenosine-induced hyperemia.
     J Nucl Cardiol. 2023;30:2504-2513.
     PubMed     Abstract available
     
     
     
214. SCIAGRA R, Linguanti F
     The Never-ending Story: Assessing coronary collateral circulation with myocardial perfusion imaging.
     J Nucl Cardiol. 2023;30:2346-2348.
     PubMed     Abstract available
     
     
     
215. REID BJ, Lindow T, Warren S, Persson E, et al
     Immediate recruitment of dormant coronary collaterals can provide more than half of normal resting perfusion during coronary occlusion in patients with coronary artery disease.
     J Nucl Cardiol. 2023;30:2338-2345.
     PubMed     Abstract available
     
     
     
216. PRETORIUS PH, Liu J, Kalluri KS, Jiang Y, et al
     Observer studies of image quality of denoising reduced-count cardiac single photon emission computed tomography myocardial perfusion imaging by three-dimensional Gaussian post-reconstruction filtering and deep learning.
     J Nucl Cardiol. 2023;30:2427-2437.
     PubMed     Abstract available
     
     
     
217. DAWDY J, Polina A, Abidov A
     Ascites and liver cirrhosis diagnosed on cardiac scintigraphic imaging.
     J Nucl Cardiol. 2023;30:2837-2838.
     PubMed    
     
     
     
218. MANNARINO T, D'Antonio A, Assante R, Zampella E, et al
     Combined evaluation of CAC score and myocardial perfusion imaging in patients at risk of cardiovascular disease: where are we and what do the data say.
     J Nucl Cardiol. 2023;30:2349-2360.
     PubMed     Abstract available
     
     
     
219. SUBRAMANIAN K, Mittal BR, Singh H, Sood A, et al
     Stigmata of portal hypertension depicted on myocardial perfusion imaging.
     J Nucl Cardiol. 2023;30:2813-2815.
     PubMed    
     
     
     
220. RAVAL M, Siddiq S
     Extra-cardiac uptake of 99mTc-pyrophosphate scan leading to the diagnosis of stage IV metastatic prostatic adenocarcinoma.
     J Nucl Cardiol. 2023;30:2807-2808.
     PubMed    
     
     
     
221. SUBRAMANIAN K, Mahdi R, Singh H, Sood A, et al
     Perfusion defect with characteristic anterior wall indentation on myocardial perfusion imaging caused by a large left ventricular aneurysm.
     J Nucl Cardiol. 2023;30:2809-2812.
     PubMed    
     
     
     
222. YAGHOOBI N, Maghsudi M, Malek H, Bakhshandeh H, et al
     Role of CT attenuation correction gated SPECT MPI in prediction of pulmonary hypertension.
     J Nucl Cardiol. 2023;31:101777.
     PubMed     Abstract available
     
     
     
223. MATTHEWS B, Duddleston D, Hage FG
     Myocardial perfusion imaging in congenitally corrected transposition of the great arteries.
     J Nucl Cardiol. 2023;30:2907-2910.
     PubMed    
     
     
     
224. BUTT F, Siegel A
     Acute intramural hematoma of the ascending aorta discovered on myocardial perfusion SPECT.
     J Nucl Cardiol. 2023;30:2841-2843.
     PubMed    
     
     
     
225. SILLANMAKI S, Iso-Mustajarvi S
     (18)F-FDG-PET of cardiac sarcoidosis with subcutaneous nodules.
     J Nucl Cardiol. 2023;30:2839-2840.
     PubMed    
     
     
     
226. DAWDY J, Polina A, Abidov A
     Ascites and liver cirrhosis diagnosed on cardiac scintigraphic imaging.
     J Nucl Cardiol. 2023;30:2837-2838.
     PubMed    
     
     
     
227. SUBRAMANIAN K, Bahl A, Singh H, Singh H, et al
     Invasive cardiac aspergillosis in an immuno-competent patient: distinctive imaging features on 18F-fluorodeoxyglucose (FDG)-PET/CT and 99mTc-sestamibi SPECT myocardial perfusion imaging.
     J Nucl Cardiol. 2023;30:2825-2827.
     PubMed    
     
     
     
228. KAUR S, Bartley P, Gordon S, Higgins A, et al
     Left ventricular assist device infection on (18)F-flourodeoxyglucose positron emission tomography.
     J Nucl Cardiol. 2023;30:2823-2824.
     PubMed     Abstract available
     
     
     
229. YAMAMOTO A, Nagao M, Inai K, Shinkawa T, et al
     Coronary microvascular dysfunction detected by (13)N-ammonia positron emission tomography in a patient with repaired aortic coarctation.
     J Nucl Cardiol. 2023;30:2819-2822.
     PubMed    
     
     
     
230. SUBRAMANIAN K, Mittal BR, Singh H, Sood A, et al
     Stigmata of portal hypertension depicted on myocardial perfusion imaging.
     J Nucl Cardiol. 2023;30:2813-2815.
     PubMed    
     
     
     
231. SUBRAMANIAN K, Mahdi R, Singh H, Sood A, et al
     Perfusion defect with characteristic anterior wall indentation on myocardial perfusion imaging caused by a large left ventricular aneurysm.
     J Nucl Cardiol. 2023;30:2809-2812.
     PubMed    
     
     
     
232. RAVAL M, Siddiq S
     Extra-cardiac uptake of 99mTc-pyrophosphate scan leading to the diagnosis of stage IV metastatic prostatic adenocarcinoma.
     J Nucl Cardiol. 2023;30:2807-2808.
     PubMed    
     
     
     
233. FITCH JS, Schwartz RG
     Detection and quantification of myocardial scar and LVEF with high efficiency digital SPECT: The expanding value proposition for clinical cardiology.
     J Nucl Cardiol. 2023;30:2803-2806.
     PubMed    
     
     
     
234. KRAKAUER M, Ismail A, Talleruphuus U, Henriksen AC, et al
     (82)Rb and [(15)O]H(2)O myocardial perfusion PET imaging: a prospective head to head comparison.
     J Nucl Cardiol. 2023;30:2790-2802.
     PubMed     Abstract available
     
     
     
235. NAKAJIMA K, Shibutani T, Massanes F, Shimizu T, et al
     Myocardial perfusion imaging with retrospective gating and integrated correction of attenuation, scatter, respiration, motion, and arrhythmia.
     J Nucl Cardiol. 2023;30:2773-2789.
     PubMed     Abstract available
     
     
     
236. JAHANDIDEH A, Virta J, Li XG, Liljenback H, et al
     Vascular adhesion protein-1-targeted PET imaging in autoimmune myocarditis.
     J Nucl Cardiol. 2023;30:2760-2772.
     PubMed     Abstract available
     
     
     
237. JUAREZ-OROZCO LE, Niemi M, Yeung MW, Benjamins JW, et al
     Hybridizing machine learning in survival analysis of cardiac PET/CT imaging.
     J Nucl Cardiol. 2023;30:2750-2759.
     PubMed     Abstract available
     
     
     
238. CHRISTENSEN NL, Nordstrom J, Madsen S, Madsen MA, et al
     Detection and correction of patient motion in dynamic (15)O-water PET MPI.
     J Nucl Cardiol. 2023;30:2736-2749.
     PubMed     Abstract available
     
     
     
239. WATANABE S, Nakajima K, Toshima F, Wakabayashi H, et al
     Transthyretin amyloid cardiomyopathy disease burden quantified using (99m)Tc-pyrophosphate SPECT/CT: volumetric parameters versus SUVmax ratio at 1 and 3 hours.
     J Nucl Cardiol. 2023;30:2721-2735.
     PubMed     Abstract available
     
     
     
240. LI L, Gao J, Chen BX, Liu X, et al
     Fibroblast activation protein imaging in atrial fibrillation: a proof-of-concept study.
     J Nucl Cardiol. 2023;30:2712-2720.
     PubMed     Abstract available
     
     
     
241. DE OLIVEIRA RS, Moll-Bernardes R, de Brito AX, Pinheiro MVT, et al
     Use of PET/CT to detect myocardial inflammation and the risk of malignant arrhythmia in chronic Chagas disease.
     J Nucl Cardiol. 2023;30:2702-2711.
     PubMed     Abstract available
     
     
     
242. KAMERMAN M, van Dijk JD, Timmer JR, Ottervanger JP, et al
     The incremental value of coronary artery calcium score in predicting long-term prognosis and defining the warranty period of normal adenosine stress-only myocardial perfusion imaging using CZT SPECT.
     J Nucl Cardiol. 2023;30:2692-2701.
     PubMed     Abstract available
     
     
     
243. ARNFIELD EG, Tam L, Pattison DA, Younger J, et al
     Cardiac metastases from neuroendocrine neoplasms: complementary role of SSTR PET/CT and cardiac MRI.
     J Nucl Cardiol. 2023;30:2676-2691.
     PubMed     Abstract available
     
     
     
244. SAN MIGUEL L, Goldschmidt E, Brisbin AK, Redruello M, et al
     A new perspective on an old method: gated SPECT imaging for left ventricular contractile function assessment.
     J Nucl Cardiol. 2023;30:2658-2665.
     PubMed     Abstract available
     
     
     
245. CAMONI L, Dondi F
     Time-efficient cardiac imaging: early post-injection stress-first protocol myocardial perfusion SPECT with a CZT camera.
     J Nucl Cardiol. 2023;30:2655-2657.
     PubMed    
     
     
     
246. CASE JA, Courter SA, McGhie A, Patel KK, et al
     Accurate and efficient rapid acquisition early post-injection stress-first CZT SPECT myocardial perfusion imaging with tetrofosmin and attenuation correction.
     J Nucl Cardiol. 2023;30:2644-2654.
     PubMed     Abstract available
     
     
     
247. GRAMBOW-VELILLA J, Mahida B, Benali K, Deconinck L, et al
     Prognosis and follow-up of patients with prosthetic valve endocarditis treated conservatively in relation to WBC-SPECT imaging.
     J Nucl Cardiol. 2023;30:2633-2643.
     PubMed     Abstract available
     
     
     
248. ZHANG J, Xie J, Li M, Fang W, et al
     SPECT myocardial blood flow quantitation for the detection of angiographic stenoses with cardiac-dedicated CZT SPECT.
     J Nucl Cardiol. 2023;30:2618-2632.
     PubMed     Abstract available
     
     
     
249. HUDSON O, Hage FG
     Single photon emission computed tomography pyrophosphate imaging for transthyretin cardiac amyloid.
     J Nucl Cardiol. 2023;30:2615-2617.
     PubMed    
     
     
     
250. AKINCIOGLU C, Murthi M, Romsa J, Warrington J, et al
     Comparison of cardio-focal and chest reconstruction of technetium-99m pyrophosphate scintigraphy for diagnosis of transthyretin cardiac amyloidosis: a quality assurance study.
     J Nucl Cardiol. 2023;30:2607-2614.
     PubMed     Abstract available
     
     
     
251. YU W, Yang L, Zhang F, Liu B, et al
     Machine learning to predict hemodynamically significant CAD based on traditional risk factors, coronary artery calcium and epicardial fat volume.
     J Nucl Cardiol. 2023;30:2593-2606.
     PubMed     Abstract available
     
     
     
252. LI L, Pang Z, Wang J, Chen Y, et al
     Prognostic value of myocardial flow reserve measured with CZT cardiac-dedicated SPECT low-dose dynamic myocardial perfusion imaging in patients with INOCA.
     J Nucl Cardiol. 2023;30:2578-2592.
     PubMed     Abstract available
     
     
     
253. CLERC OF, Frey SM, Honegger U, Amrein MLF, et al
     Coronary artery calcium score and pre-test probabilities as gatekeepers to predict and rule out perfusion defects in positron emission tomography.
     J Nucl Cardiol. 2023;30:2559-2573.
     PubMed     Abstract available
     
     
     
254. SAZONOVA SI, Ilyushenkova JN, Syrkina AG, Trusov AA, et al
     Potential utility of SPECT/CT with 99mTc-Tektrotyd for imaging of post-myocardial infarction inflammation.
     J Nucl Cardiol. 2023;30:2544-2555.
     PubMed     Abstract available
     
     
     
255. KHOR YM, Dorbala S
     Extra-cardiac uptake on technetium-99m pyrophosphate (Tc-99m PYP) scan: not just a matter of the heart.
     J Nucl Cardiol. 2023;30:2540-2543.
     PubMed    
     
     
     
256. KHERAJANI P, Farag AA, Morgan WS, Hage FG, et al
     Complete resolution of focal-on-diffuse myocardial activity pattern on FDG PET-CT by prolonging the dietary preparation protocol in cardiac sarcoidosis.
     J Nucl Cardiol. 2023;30:2525-2530.
     PubMed     Abstract available
     
     
     
257. ADHADUK M, Paudel B, Liu K, Ashwath M, et al
     Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of myocardial viability: meta-analysis and systematic review.
     J Nucl Cardiol. 2023;30:2514-2524.
     PubMed     Abstract available
     
     
     
258. LASSEN ML, Byrne C, Hartmann JP, Kjaer A, et al
     Pulmonary blood volume assessment from a standard cardiac rubidium-82 imaging protocol: impact of adenosine-induced hyperemia.
     J Nucl Cardiol. 2023;30:2504-2513.
     PubMed     Abstract available
     
     
     
259. JOHN LA, Tedrow UB, Divakaran S
     Can FDG PET/CT predict AV nodal recovery in cardiac sarcoidosis?
     J Nucl Cardiol. 2023;30:2501-2503.
     PubMed    
     
     
     
260. LUCINIAN YA, Martineau P, Poenaru R, Tremblay-Gravel M, et al
     FDG-PET/CT and rest myocardial perfusion imaging to predict high-degree atrioventricular block recovery in cardiac sarcoidosis.
     J Nucl Cardiol. 2023;30:2490-2500.
     PubMed     Abstract available
     
     
     
261. TAVOOSI A, Khetarpal R, Wells RG, Beanlands RSB, et al
     Exponential dosing to standardize myocardial perfusion image quality with rubidium-82 PET.
     J Nucl Cardiol. 2023;30:2477-2489.
     PubMed     Abstract available
     
     
     
262. AHLUWALIA N, Roshankar G, Draycott L, Jimenez-Zepeda V, et al
     Diagnostic accuracy of bone scintigraphy imaging for transthyretin cardiac amyloidosis: systematic review and meta-analysis.
     J Nucl Cardiol. 2023;30:2464-2476.
     PubMed     Abstract available
     
     
     
263. CHAN SH, Huang CK, Luzhbin D, Hou PN, et al
     Meta-analysis of the effectiveness of heparin in suppressing physiological myocardial FDG uptake in PET/CT.
     J Nucl Cardiol. 2023;30:2454-2463.
     PubMed     Abstract available
     
     
     
264. PRETORIUS PH, Liu J, Kalluri KS, Jiang Y, et al
     Observer studies of image quality of denoising reduced-count cardiac single photon emission computed tomography myocardial perfusion imaging by three-dimensional Gaussian post-reconstruction filtering and deep learning.
     J Nucl Cardiol. 2023;30:2427-2437.
     PubMed     Abstract available
     
     
     
265. HANSEN CL
     Improving evaluation for TTR amyloidosis by interactive filtering of Tc-99 m PYP SPECT images. The role for "clean blood pool" imaging.
     J Nucl Cardiol. 2023;30:2418-2426.
     PubMed     Abstract available
     
     
     
266. SAG SJM, Menhart K, Hitzenbichler F, Schmid C, et al
     (18)F-FDG PET/CT-derived total lesion glycolysis predicts abscess formation in patients with surgically confirmed infective endocarditis: Results of a retrospective study at a tertiary center.
     J Nucl Cardiol. 2023;30:2400-2414.
     PubMed     Abstract available
     
     
     
267. KITAGAWA T, Sasaki K, Fujii Y, Ikegami Y, et al
     (18)F-sodium fluoride positron emission tomography following coronary computed tomography angiography in predicting long-term coronary events: a 5-year follow-up study.
     J Nucl Cardiol. 2023;30:2365-2378.
     PubMed     Abstract available
     
     
     
268. MANNARINO T, D'Antonio A, Assante R, Zampella E, et al
     Combined evaluation of CAC score and myocardial perfusion imaging in patients at risk of cardiovascular disease: where are we and what do the data say.
     J Nucl Cardiol. 2023;30:2349-2360.
     PubMed     Abstract available
     
     
     
269. SCIAGRA R, Linguanti F
     The Never-ending Story: Assessing coronary collateral circulation with myocardial perfusion imaging.
     J Nucl Cardiol. 2023;30:2346-2348.
     PubMed     Abstract available
     
     
     
270. PICCINELLI M, Cooke CD, Folks R, Garcia EV, et al
     4D display of CT LV endocardial and epicardial models morphed from PET Rb-82 perfusion studies accurately quantifies segmental myocardial thickening.
     J Nucl Cardiol. 2023;30:2314-2326.
     PubMed     Abstract available
     
     
     
271. ROZANSKI A, Gransar H, Sakul S, Miller RJH, et al
     Increasing frequency of dyspnea among patients referred for cardiac stress testing.
     J Nucl Cardiol. 2023;30:2303-2313.
     PubMed     Abstract available
     
     
     
272. LIMA BB, Benz DC
     Casting aside the creep: harnessing cardiorespiratory dynamics to optimize myocardial flow assessment in cardiac PET.
     J Nucl Cardiol. 2023;30:2301-2302.
     PubMed    
     
     
     
273. LASSEN ML, Rasmussen T, Byrne C, Holmvang L, et al
     Myocardial creep and cardiorespiratory motion correction improves diagnostic accuracy of Rubidium-82 cardiac positron emission tomography.
     J Nucl Cardiol. 2023;30:2289-2300.
     PubMed     Abstract available
     
     
     
274. BATEMAN TM
     In 2023 PET myocardial perfusion imaging is preferred to invasive coronary angiography for the initial work-up of a symptomatic patient with a high coronary artery calcium score.
     J Nucl Cardiol. 2023;30:2273-2278.
     PubMed    
     
     
     
275. JOHNSRUD DO, Port SC
     In 2023 invasive coronary angiography is preferred to PET myocardial perfusion imaging for the initial work-up of a symptomatic patient with a high coronary artery calcium score.
     J Nucl Cardiol. 2023;30:2269-2272.
     PubMed    
     
     
     November 2023
276. BATEMAN TM
     In 2023 PET myocardial perfusion imaging is preferred to invasive coronary angiography for the initial work-up of a symptomatic patient with a high coronary artery calcium score.
     J Nucl Cardiol. 2023 Nov 10. doi: 10.1007/s12350-023-03386.
     PubMed    
     
     
     
277. KAMERMAN M, van Dijk JD, Timmer JR, Ottervanger JP, et al
     Correction to: The incremental value of coronary artery calcium score in predicting long-term prognosis and defining the warranty period of normal adenosine stress-only myocardial perfusion imaging using CZT SPECT.
     J Nucl Cardiol. 2023 Nov 6. doi: 10.1007/s12350-023-03389.
     PubMed    
     
     
     October 2023
278. CHAREONTHAITAWEE P, Bateman TM, Beanlands RS, Berman DS, et al
     Atlas for reporting PET myocardial perfusion imaging and myocardial blood flow in clinical practice: an information statement from the American Society of Nuclear Cardiology.
     J Nucl Cardiol. 2023 Oct 27. doi: 10.1007/s12350-023-03378.
     PubMed    
     
     
     
279. JOHNSRUD DO, Port SC
     In 2023 invasive coronary angiography is preferred to PET myocardial perfusion imaging for the initial work-up of a symptomatic patient with a high coronary artery calcium score.
     J Nucl Cardiol. 2023 Oct 16. doi: 10.1007/s12350-023-03385.
     PubMed    
     
     
     
280. KRAKAUER M, Ismail A, Talleruphuus U, Henriksen AC, et al
     (82)Rb and [(15)O]H(2)O myocardial perfusion PET imaging: a prospective head to head comparison.
     J Nucl Cardiol. 2023 Oct 3. doi: 10.1007/s12350-023-03372.
     PubMed     Abstract available
     
     
     
281. LOHARKAR S, Sonavane SN, Shah H, Basu S, et al
     What is this image? 2023 Image 3 results: Cardiac tuberculosis presenting as cardiac mass: role of (18)F-FDG PET/CT in monitoring response to treatment.
     J Nucl Cardiol. 2023 Oct 2. doi: 10.1007/s12350-023-03381.
     PubMed    
     
     
     
282. MAIR BA, Zelt JGE, Nekesa K, Saint-Georges Z, et al
     Pharmacological and metabolic parameters of [(18)F]flubrobenguane in clinical imaging populations.
     J Nucl Cardiol. 2023;30:2089-2095.
     PubMed     Abstract available
     
     
     
283. BULLOCK-PALMER RP
     Utility of myocardial blood flow assessment with dynamic CZT single photon emission computed tomography in patients with myocardial bridging: Is this 'wishful thinking' in this dynamic situation?
     J Nucl Cardiol. 2023;30:2068-2072.
     PubMed    
     
     
     
284. IBRAHIM J, Soman P
     The past, present, and future of attenuation correction for myocardial perfusion imaging.
     J Nucl Cardiol. 2023;30:1794-1796.
     PubMed    
     
     
     
285. TOTTLEBEN J, Torres A, Doukky R
     Impact of change of ischemic burden on the outcomes of ESRD patients awaiting kidney transplantation.
     J Nucl Cardiol. 2023;30:1897-1903.
     PubMed     Abstract available
     
     
     
286. DAKIK HA, Ghazzal Z, Haidar M
     Screening asymptomatic patients post PCI with myocardial perfusion imaging.
     J Nucl Cardiol. 2023;30:2248-2251.
     PubMed    
     
     
     
287. NAYFEH M, Ahmed AI, Al-Mallah MH
     Unveiling the hidden link: deciphering the interplay between plaque characteristics and nuclear myocardial perfusion imaging.
     J Nucl Cardiol. 2023;30:1851-1855.
     PubMed    
     
     
     
288. HEDEER F, Akil S, Oddstig J, Hindorf C, et al
     Diagnostic accuracy for CZT gamma camera compared to conventional gamma camera technique with myocardial perfusion single-photon emission computed tomography: Assessment of myocardial infarction and function.
     J Nucl Cardiol. 2023;30:1935-1946.
     PubMed     Abstract available
     
     
     
289. AL TAHA Z, Alibazoglu D, Sabbour H, Romany I, et al
     Attacking the Achilles heel of cardiac amyloid nuclear scintigraphy: How to reduce equivocal and false positive studies.
     J Nucl Cardiol. 2023;30:1922-1934.
     PubMed     Abstract available
     
     
     
290. WANG Y, Yu W, Yang X, Zhang F, et al
     Left ventricular systolic dyssynchrony: a novel imaging marker for early assessment of myocardial damage in Chinese type 2 diabetes mellitus patients with normal left ventricular ejection fraction and normal myocardial perfusion.
     J Nucl Cardiol. 2023;30:1797-1809.
     PubMed     Abstract available
     
     
     
291. VALZANIA C, Paccagnella A, Spadotto A, Ruotolo I, et al
     Early detection of cancer therapy cardiotoxicity by radionuclide angiography: An update.
     J Nucl Cardiol. 2023;30:2104-2111.
     PubMed     Abstract available
     
     
     
292. ANDERSSON Y, Fernandez G, Mars P, Lindow T, et al
     Significant myocardial perfusion defect during stress visible in prone but not in supine imaging.
     J Nucl Cardiol. 2023;30:2209-2212.
     PubMed    
     
     
     
293. DORAN JA, Sajjad W, Schneider MD, Gupta R, et al
     Retraction Note: Aminophylline and caffeine for reversal of adverse symptoms associated with regadenoson SPECT MPI.
     J Nucl Cardiol. 2023;30:2254.
     PubMed    
     
     
     
294. NIELSEN MO, Schledermann H, Jensen LT
     Primary breast cancer diagnosed by 82-Rubidium myocardial perfusion PET-scan.
     J Nucl Cardiol. 2023;30:2252-2253.
     PubMed    
     
     
     
295. DAKIK HA, Ghazzal Z, Haidar M
     Screening asymptomatic patients post PCI with myocardial perfusion imaging.
     J Nucl Cardiol. 2023;30:2248-2251.
     PubMed    
     
     
     
296. CHEN LQ, Nichols KJ, Van Tosh A
     Exercise ECG must be considered in conjunction with conventional SPECT.
     J Nucl Cardiol. 2023;30:2245-2247.
     PubMed    
     
     
     
297. SUTHERLAND N, Sivaratnam D, Pearson M, Better N, et al
     Use of SPECT imaging to confirm ATTR cardiac amyloid in a Tc99m pyrophosphate study artefactually compromised by a recent V/Q scan.
     J Nucl Cardiol. 2023;30:2242-2244.
     PubMed    
     
     
     
298. AIKAWA T, Manabe O, Ibe T, Oyama-Manabe N, et al
     Serial assessment of cardiac involvement in sarcoidosis by delayed (18)F-fluorodeoxyglucose PET/CT.
     J Nucl Cardiol. 2023;30:2225-2228.
     PubMed    
     
     
     
299. ZMAILI M, Jaber W
     First experience of LVEF assessment with cardiac amyloid SPECT scan.
     J Nucl Cardiol. 2023;30:2222-2224.
     PubMed    
     
     
     
300. TAKAHASHI K, Morioka H, Sasaki D, Yamamura N, et al
     Two autopsy cases of wild-type transthyretin cardiac amyloidosis who died 10 days after technetium-99m-pyrophosphate scintigraphy.
     J Nucl Cardiol. 2023;30:2215-2221.
     PubMed    
     
     
     
301. JALEEL J, Patel C, Khangembam B, Kumar S, et al
     Utility of 68Ga-DOTANOC PET/CT in therapeutic monitoring of cardiac sarcoidosis.
     J Nucl Cardiol. 2023;30:2213-2214.
     PubMed     Abstract available
     
     
     
302. TAKAHASHI K, Sasaki D, Uemura S, Okura T, et al
     (99m)Tc-PYP SPECT/CT as part of the diagnostic workup of left ventricular apical aneurysm in a patient with hypertrophic cardiomyopathy.
     J Nucl Cardiol. 2023;30:2198-2203.
     PubMed    
     
     
     
303. QAMAR I, Grewal S, Fahed AC, Weiner R, et al
     PET myocardial perfusion imaging of regadenoson-induced coronary vasospasm.
     J Nucl Cardiol. 2023;30:2187-2190.
     PubMed    
     
     
     
304. DILSIZIAN V, Bacharach SL, Beanlands RS, Bergmann SR, et al
     Correction to: ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures.
     J Nucl Cardiol. 2023;30:2186.
     PubMed    
     
     
     
305. HORGAN S, Sanghani R, Miller S, Al-Mallah M, et al
     ASNC model coverage policy: 2023 cardiac positron emission tomography.
     J Nucl Cardiol. 2023;30:2114-2185.
     PubMed    
     
     
     
306. VALZANIA C, Paccagnella A, Spadotto A, Ruotolo I, et al
     Early detection of cancer therapy cardiotoxicity by radionuclide angiography: An update.
     J Nucl Cardiol. 2023;30:2104-2111.
     PubMed     Abstract available
     
     
     
307. BUCY L, Erpelding ML, Boursier C, Lefevre B, et al
     Real world experience of therapeutic monitoring of medically treated prosthetic valve infective endocarditis by (18)F-FDG-PET/CT.
     J Nucl Cardiol. 2023;30:2096-2103.
     PubMed     Abstract available
     
     
     
308. MAIR BA, Zelt JGE, Nekesa K, Saint-Georges Z, et al
     Pharmacological and metabolic parameters of [(18)F]flubrobenguane in clinical imaging populations.
     J Nucl Cardiol. 2023;30:2089-2095.
     PubMed     Abstract available
     
     
     
309. BENTSEN S, Jensen JK, Christensen E, Petersen LR, et al
     [(68)Ga]Ga-NODAGA-E[(cRGDyK)](2) angiogenesis PET following myocardial infarction in an experimental rat model predicts cardiac functional parameters and development of heart failure.
     J Nucl Cardiol. 2023;30:2073-2084.
     PubMed     Abstract available
     
     
     
310. BULLOCK-PALMER RP
     Utility of myocardial blood flow assessment with dynamic CZT single photon emission computed tomography in patients with myocardial bridging: Is this 'wishful thinking' in this dynamic situation?
     J Nucl Cardiol. 2023;30:2068-2072.
     PubMed    
     
     
     
311. XU R, Yang H, Zhang J, Chen S, et al
     Dynamic perfusion SPECT for functional evaluation in symptomatic patients with myocardial bridging.
     J Nucl Cardiol. 2023;30:2058-2067.
     PubMed     Abstract available
     
     
     
312. PETRETTA M, Panico M, Mainolfi CG, Cuocolo A, et al
     Including myocardial flow reserve by PET in prediction models: Ready to fly?
     J Nucl Cardiol. 2023;30:2054-2057.
     PubMed    
     
     
     
313. MIURA S, Okizaki A, Kumamaru H, Manabe O, et al
     Interaction of impaired myocardial flow reserve and extent of myocardial ischemia assessed using (13)N-ammonia positron emission tomography imaging on adverse cardiovascular outcomes.
     J Nucl Cardiol. 2023;30:2043-2053.
     PubMed     Abstract available
     
     
     
314. HULTEN E, Keating FK
     Diagnosis of diffuse ischemia with SPECT relative perfusion imaging: How to eat soup with a fork?
     J Nucl Cardiol. 2023;30:2039-2042.
     PubMed    
     
     
     
315. KUPUSOVIC J, Kessler L, Bruns F, Bohnen JE, et al
     Visualization of fibroblast activation using (68)Ga-FAPI PET/CT after pulmonary vein isolation with pulsed field compared with cryoballoon ablation.
     J Nucl Cardiol. 2023;30:2018-2028.
     PubMed     Abstract available
     
     
     
316. MALLET F, Poitrasson-Riviere A, Mariano-Goulart D, Agostini D, et al
     Measuring myocardial blood flow using dynamic myocardial perfusion SPECT: artifacts and pitfalls.
     J Nucl Cardiol. 2023;30:2006-2017.
     PubMed     Abstract available
     
     
     
317. DAI N, Zhang B, Gong Z, Dong Z, et al
     Quantitative flow ratio derived pullback pressure gradient and CZT-SPECT measured longitudinal flow gradient for hemodynamically significant coronary artery disease.
     J Nucl Cardiol. 2023;30:1992-2002.
     PubMed     Abstract available
     
     
     
318. WANG A, Mahmood U, Tang X, Jain D, et al
     A case of disappearing amyloid on technetium pyrophosphate scan.
     J Nucl Cardiol. 2023;30:1986-1991.
     PubMed     Abstract available
     
     
     
319. TANG X, Dai N, Zhang B, Cai H, et al
     Comparison of 2D-QCA, 3D-QCA and coronary angiography derived FFR in predicting myocardial ischemia assessed by CZT-SPECT MPI.
     J Nucl Cardiol. 2023;30:1973-1982.
     PubMed     Abstract available
     
     
     
320. NAKAJIMA K, Shibutani T
     Are nuclear medicine images quantified in 2D and 3D equally functional?
     J Nucl Cardiol. 2023;30:1968-1972.
     PubMed    
     
     
     
321. IMOTO A, Tateishi E, Murakawa K, Ohta Y, et al
     Lung-to-heart ratio analysis using virtual planar images obtained from myocardial perfusion SPECT data: A phantom and clinical studies.
     J Nucl Cardiol. 2023;30:1959-1967.
     PubMed     Abstract available
     
     
     
322. FUKUSHIMA K, Endo K, Yamakuni R, Kiko T, et al
     Simultaneous assessment of left ventricular mechanical dyssynchrony using integrated (13)N-ammonia PETMR system: direct comparison of PET phase analysis and MR feature tracking.
     J Nucl Cardiol. 2023;30:1947-1958.
     PubMed     Abstract available
     
     
     
323. HEDEER F, Akil S, Oddstig J, Hindorf C, et al
     Diagnostic accuracy for CZT gamma camera compared to conventional gamma camera technique with myocardial perfusion single-photon emission computed tomography: Assessment of myocardial infarction and function.
     J Nucl Cardiol. 2023;30:1935-1946.
     PubMed     Abstract available
     
     
     
324. AL TAHA Z, Alibazoglu D, Sabbour H, Romany I, et al
     Attacking the Achilles heel of cardiac amyloid nuclear scintigraphy: How to reduce equivocal and false positive studies.
     J Nucl Cardiol. 2023;30:1922-1934.
     PubMed     Abstract available
     
     
     
325. QUTBI M
     Adjustment of acquisition arc in cardiac malposition during myocardial perfusion SPECT imaging: computer simulation based on deterministic modeling.
     J Nucl Cardiol. 2023;30:1910-1921.
     PubMed     Abstract available
     
     
     
326. TOTTLEBEN J, Torres A, Doukky R
     Impact of change of ischemic burden on the outcomes of ESRD patients awaiting kidney transplantation.
     J Nucl Cardiol. 2023;30:1897-1903.
     PubMed     Abstract available
     
     
     
327. KOENDERS SS, van Dalen JA, Jager PL, Mouden M, et al
     Patient-tailored risk assessment of obstructive coronary artery disease using Rubidium-82 PET-based myocardial flow quantification with visual interpretation.
     J Nucl Cardiol. 2023;30:1890-1896.
     PubMed     Abstract available
     
     
     
328. HANAOKA K, Watanabe S, Morimoto-Ishikawa D, Kaida H, et al
     Impact of respiratory gating and ECG gating on (18)F-FDG PET/CT for cardiac sarcoidosis.
     J Nucl Cardiol. 2023;30:1879-1885.
     PubMed     Abstract available
     
     
     
329. CHEN X, Liu C
     Deep-learning-based methods of attenuation correction for SPECT and PET.
     J Nucl Cardiol. 2023;30:1859-1878.
     PubMed     Abstract available
     
     
     
330. NAYFEH M, Ahmed AI, Al-Mallah MH
     Unveiling the hidden link: deciphering the interplay between plaque characteristics and nuclear myocardial perfusion imaging.
     J Nucl Cardiol. 2023;30:1851-1855.
     PubMed    
     
     
     
331. HIJAZI W, Miller RJH
     Deep learning to automate SPECT MPI myocardial reorientation.
     J Nucl Cardiol. 2023;30:1836-1837.
     PubMed    
     
     
     
332. ZHU F, Wang G, Zhao C, Malhotra S, et al
     Automatic reorientation by deep learning to generate short-axis SPECT myocardial perfusion images.
     J Nucl Cardiol. 2023;30:1825-1835.
     PubMed     Abstract available
     
     
     
333. GATTERER C, Wollenweber T, Pichler V, Vraka C, et al
     Detection of sympathetic denervation defects in Fabry disease by hybrid [(11)C]meta-hydroxyephedrine positron emission tomography and cardiac magnetic resonance.
     J Nucl Cardiol. 2023;30:1810-1821.
     PubMed     Abstract available
     
     
     
334. WANG Y, Yu W, Yang X, Zhang F, et al
     Left ventricular systolic dyssynchrony: a novel imaging marker for early assessment of myocardial damage in Chinese type 2 diabetes mellitus patients with normal left ventricular ejection fraction and normal myocardial perfusion.
     J Nucl Cardiol. 2023;30:1797-1809.
     PubMed     Abstract available
     
     
     
335. IBRAHIM J, Soman P
     The past, present, and future of attenuation correction for myocardial perfusion imaging.
     J Nucl Cardiol. 2023;30:1794-1796.
     PubMed    
     
     
     
336. CHOPRA S, Singh SS, Sood A, Parmar M, et al
     Comparison of positional artifacts in myocardial perfusion imaging in supine and semi-reclining position using dedicated D-SPECT cardiac camera: validation using CT based attenuation correction.
     J Nucl Cardiol. 2023;30:1782-1793.
     PubMed     Abstract available
     
     
     
337. SALEH JK, Barkmeier D, Frey KA, Davenport MS, et al
     Diagnostic yield of whole-body (18)F-FDG PET/CT in patients with suspected cardiac sarcoidosis.
     J Nucl Cardiol. 2023;30:1773-1781.
     PubMed     Abstract available
     
     
     
338. KUPUSOVIC J, Weber M, Bruns F, Kessler L, et al
     PET/CT-identified atrial hypermetabolism is an index of atrial inflammation in patients with atrial fibrillation.
     J Nucl Cardiol. 2023;30:1761-1772.
     PubMed     Abstract available
     
     
     
339. BERMAN DS
     Making fair comparisons: The potency and necessity of combining myocardial perfusion imaging and CAC scanning.
     J Nucl Cardiol. 2023;30:1751-1755.
     PubMed    
     
     
     
340. BERMAN DS
     Making fair comparisons: The potency and necessity of combining myocardial perfusion imaging and CAC scanning.
     J Nucl Cardiol. 2023;30:1751-1755.
     PubMed    
     
     
     September 2023
341. JAHANDIDEH A, Virta J, Li XG, Liljenback H, et al
     Vascular adhesion protein-1-targeted PET imaging in autoimmune myocarditis.
     J Nucl Cardiol. 2023 Sep 27. doi: 10.1007/s12350-023-03371.
     PubMed     Abstract available
     
     
     
342. ADHADUK M, Paudel B, Liu K, Ashwath M, et al
     Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of myocardial viability: meta-analysis and systematic review.
     J Nucl Cardiol. 2023 Sep 27. doi: 10.1007/s12350-023-03377.
     PubMed     Abstract available
     
     
     
343. LIMA BB, Benz DC
     Casting aside the creep: harnessing cardiorespiratory dynamics to optimize myocardial flow assessment in cardiac PET.
     J Nucl Cardiol. 2023 Sep 20. doi: 10.1007/s12350-023-03376.
     PubMed    
     
     
     
344. HORGAN S, Sanghani R, Miller S, Al-Mallah M, et al
     ASNC model coverage policy: 2023 cardiac positron emission tomography.
     J Nucl Cardiol. 2023 Sep 5. doi: 10.1007/s12350-023-03355.
     PubMed    
     
     
     August 2023
345. MIYATAKE M, Norikane T, Imajo M, Takami Y, et al
     LV functional evaluation on (11)C-PiB PET/CT in cardiac amyloidosis.
     J Nucl Cardiol. 2023;30:1693-1696.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.